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ABSTRACT
Studies were conducted to investigate the prevalence and potential for transfer of
class 1 integrons and antimicrobial resistance in bacteria of broiler chickens and swine
from the US and Thailand. Antibiograms were characterized and integron sequences were
detected using standard methods. To determine if transfer of integrons occurred between
bacterial species the location of the integrons (plasmid versus chromosome) was
determined, and when integron-positive E. coli and Salmonella isolates possessed
identical amplicon patterns, PCR products were sequenced to determine homology. Class
1 integrons were detected in 1,732 of 3,824 isolates from broiler chickens and 1,782 of
4,253 isolates from swine. Simultaneous presence of three conserved class 1 integron
genes was found in 1,044 and 215 of isolates from chickens and swine, respectively. A
high proportion of bacterial isolates from chickens demonstrated resistance to
tetracycline, sulfamethoxazole, cephalothin, and ampicillin. A high proportion of isolates
from swine demonstrated resistance to tetracycline, sulfamethoxazole, streptomycin, and
ampicillin. Nine integron amplicons, with sizes ranging from 0.5 to 2.5 kb, were found,
and we discovered a single swine farm on which similar integrons were observed in both
E. coli and Salmonella. Sequence analysis revealed that a 1.0 kb amplicon found in both
bacterial species contained an aadA1 gene cassette encoding aminoglycosides 3’adenyltransferase, confering resistance to streptomycin and spectinomycin. A 2.0 kb
amplicon was also found in both types of bacteria containing the aadA5 gene encoding
aminoglycosides 3’-adenyltransferase, an additional reading frame with unknown
function, orfD, as well as a dfrA17 gene encoding dihydrofolate reductase, conferring
iii

resistance to trimethoprim. Our results indicate that class 1 integrons are common in
commensal and foodborne bacteria in broiler chickens and swine, and that some, but not
all antibiotic resistances are associated with the presence of class 1 integrons. Identical
integrons found in Salmonella and E. coli from a single farm likely indicate transfer
between these two organisms occurs via exchange of plasmids. This work provides
additional knowledge regarding the complex nature of antibiotic resistance gene
acquisition, reservoirs, and transfer that should aid in development of courses of action
and strategies for control of these potential foodborne and zoonotic hazards.
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CHAPTER 1 : INTRODUCTION

1

Since their discovery early in the 20th century, antibiotics have remained in
extensive use for human and animal therapies. Subsequently, in the 1950s, antimicrobial
compounds were found to produce consistent benefits in livestock production and have
thus been used extensively to enhance growth and efficiency of animals, and thus
profitability of production systems. However, significant evidence exists indicating that
continued and extensive use of antibiotics for human medicine and animal production has
led to an increased prevalence of drug-resistant bacteria, possibly affecting the long term
usefulness of these important compounds (1). Of primary concern is a loss of efficacy of
antibiotics that may offer a last line of defense against multi-resistant bacteria (3, 7).
Thus, the use of some antimicrobial compounds, such as vancomycin and
fluoroquinolones, has come under great scrutiny. While a number of studies have been
conducted to characterize factors affecting resistance to derive strategies for control, a
common consensus remains that too little information is available to guide appropriate
agencies in formulation of regulations for agricultural use of antimicrobials (4).
A number of factors appear to affect the dissemination of resistance genes and
thus prevalence of antimicrobial resistance in bacteria associated with livestock. These
factors may include animal age, stress, husbandry practices, and on-farm use of
antimicrobials (4, 10-13). The majority of methods by which bacteria become resistant
involve the acquisition of exogenous DNA that confers the ability to resist an
antimicrobial drug. Such acquisition typically takes the form of transduction by phage,
appropriation of transposable DNA, and/or the reception of plasmid DNA.
In recent years, many resistance genes isolated from bacteria have been mapped
to specific genome sites known as integrons. Integrons have been found in plasmids,
2

transposons, and as independent units on bacterial chromosomes (2, 5, 8). By definition,
integrons contain three elements that allow the site-specific recombination of antibiotic
resistance genes. These elements include: 1) a recombination or attachment site; 2) an
integrase, which recognizes specific sequences on the extra-integron gene cassette and
the recombination site; and 3) a strong promoter that allows the integron to act as an
expression vector in the event of the incorporation of promoterless cassettes (9, 14). As
such, bacteria that harbor integrons may have an enhanced ability to rapidly develop
resistance to multiple antibiotics, and to promote the transfer of highly stable and selfpromoting resistance factors across their own and other bacterial species. Thus, bacteria
containing integrons pose a particularly insidious threat to the efficacies of current as
well as future antimicrobials. And while it is proposed that the primary vehicle for
transfer of bacterial resistance genes from animal hosts to human hosts is through food
borne bacteria, the large pool of naturally occurring nonpathogenic bacteria in the gut,
including E. coli, has been proposed to act as a reservoir of and/or vector for transferable
resistance genes. These commensal bacteria, by their residence in the GI tract, are
subject to exposure from antibiotics included in feeds and water, and they have been
shown to acquire resistance following such exposure (10-12) demonstrating a higher
prevalence of resistance genes and genetic resistance elements, including integrons (6). It
is widely accepted that these genes are transferable across species of bacteria, and thus
the potential exists for transfer from resident E. coli and other naturally occurring bacteria
to transient animal and human pathogens, including Salmonella. However, to date, little
evidence has been presented to clearly show that such transfer is common in vivo.

3

Understandably, representatives from consumer groups, the livestock industry,
and government agencies continue to call for more information in order that sensible and
effective recommendations to reduce antimicrobial resistance can be formulated. Through
this proposed work, we hope to further the understanding of factors that promote
antibiotic resistance and the prevalence of integrons and other resistance elements in
bacteria associated with livestock.
The U.S. and Thailand, while occupying very diverse geographic regions, share
many commonalities in livestock production practices. Both swine and poultry
production tends to be intensive, with closed confinement, high biosecurity and similar
high production genetic lines. Feed-based antibiotics are commonly used in both
countries, although some differences occur in drugs of choice and/or availability. A
comparison of antibiotic resistance genes and resistance prevalence between these two
countries may provide information regarding global implications of agricultural use of
antibiotics with regard to antibiotic resistance.
The hypothesis of this study is that antimicrobial resistance genes and transferable
genetic units are common in bacteria associated with livestock, and prevalence may be
affected by antibiotic use practices, livestock species, and geographic region. This study
further proposes that resistance genes may be shared among non-pathogenic bacteria and
foodborne pathogens that may concurrently reside within production animals. Therefore,
this study was designed to investigate resistance patterns and prevalence of specific
antimicrobial resistance genes and class 1 integrons in E. coli and Salmonella among
swine and poultry in the US and Thailand. As a possible indication of gene transfer, we
determined the degree of homology of resistance genes and integron sequences between
4

those two groups of bacteria within animals and farms. Data generated from the US and
Thailand was compared to determine if similar patterns exist across these diverse
geographic regions.

5
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I. ANTIBIOTICS
Definition and Classification of Antibiotics
The term antibiotic, from the Greek anti, meaning “against” and biotikos,
meaning “concerning life”, first appeared in a scientific letter in 1942 by Waksman (224,
225) to describe a newly discovered compound that specifically inhibited the growth of
other microorganisms. The term antibiotic originally described only those compounds
derived from microbial origin; however, it now extends to include any low-molecular
weight compound, whether from microbial or other living organisms or even of semisynthetic or synthetic origin, that can inhibit the growth or kill other microorganisms. The
majority of antibiotics used in human and veterinary medicine are natural products
produced by three main groups of microorganisms: actinomycetes, eubacteria, and
filamentous fungi. The actinomycetes produce the largest number and greatest variety of
antibiotics, with more than six thousand substances isolated from that group of microbes
(114).
Antibiotic agents can be classified according to various criteria. Based on target
microorganism, antibiotics are classified as antibacterial, antiviral, antifungal and
antiparasitic. Although some drugs can target both bacteria and protozoa (e.g.
ionophores used for control coccidiosis can also kill some Gram-positive bacteria), all
antibacterials are inactive against viruses and fungi at normal therapeutic concentrations
(84). On the basis of the spectrum of drugs, antibacterial agents can be classified as
broad- or narrow-spectrum drugs (84, 122) . Broad-spectrum drugs are generally active
against a wide variety of bacterial species, including Gram-positive, Gram-negative,
10

aerobic, and anaerobic microorganisms. Tetracycline, phenical, fluoroquinolones, thirdand fourth-generation cephalosporins, and carbapenem are examples of broad-spectrum
antibiotics. Drugs with narrower-spectra are mainly active against specific bacterial
groups such as Gram-negative bacteria (polymyxins), Gram-positive bacteria
(glycopeptide, natural penicillin), aerobes (aminoglycosides and sulfonamide), or
anaerobe (nitroimidazoles) (84). Based on antibacterial activity of the drug, antibacterials
are classified as bacteriolytic, bactericidal, and bacteriostatic. Bacteriolytic and
bactericidal antibiotics both kill bacterial cells; however, bacteriolytic antibiotics induce
killing by cell lysis and include those antibiotics that inhibit cell wall synthesis and those
that damage cell membranes. In contrast, bactericidal antibiotics kill the organism but do
not always rupture or lyse the cell. Antibiotics that inhibit the growth but do not kill are
known as bacteriostatic. Bacteriostatic antibiotics often inhibit protein synthesis and act
by binding to ribosomes. The type of antibacterial activity of a drug depends on how the
drug binds to its target. Usually, drugs that kill bacterial cells bind to their target
irreversibly or with high affinity and are not removed by dilution, whereas bacteriostatic
drugs form unstable bonds, therefore when concentration is lowered, it becomes free
from the target and the bacterium resumes growth. Sometimes, bactericidal and
bacteriolytic drugs can appear as bacteriostatic if effective killing concentrations in blood
and tissue are not achieved (155).

Antibiotics Use in Livestock Production
Antibiotics are used in food animals for four main purposes: therapeutic use to
treat diseased animals, metaphylaxis or short term medication to treat diseased animals
11

and prevent infection in other animals, prophylactic use to prevent infections at times of
risk, such as transport or weaning, and growth promotion to improve feed utilization and
production (Table 1) (140, 219).

Benefits of Antibiotic Use in Agriculture
Potential benefits associated with using antibiotics in food animals include the
treatment of disease, improvement of carcass quality, and improvement of feed efficiency
(10). The use of feed-based antibiotics has consistently been shown to benefit livestock
production, increasing the ability of farms to maintain profitable margins (52, 155, 165),
lowering manure output and thus reducing effects of animal wastes on the environment
(180), and lowering animal pathogen loads and carriage of foodborne pathogens in
livestock (68, 87, 123). Many foodborne pathogens are not easily controlled in livestock
by vaccines, and as these organisms have a commensal association with their food animal
hosts, making eradication difficult, if not impossible. However, limiting their numbers in
the gut with feed based antibiotics or water additives may be a practical approach to
limiting foodborne transfer of these organisms (165).

Given the above, it appears

prudent that such benefits be included in risk assessment models evaluating antibiotic use
in food animals, so that more realistic evaluations result and a balance is achieved that
provides the greatest protection from inherent risks while maximizing the overall benefits
to society.

12

Table 1. Types of antimicrobials use in food animals. 1,2
Type of
antimicrobial use

Purpose

Route or vehicle of
administration

Therapeutic

Therapy

Metaphylactic
Prophylactic

Disease prophylaxis, therapy Injection, feed, water
Disease prevention
Feed

Group
Group

Subtherapeutic

Growth promotion
Feed efficiency
Disease prophylaxis

Group
Group
Group

1
2

Injection, feed, water

Administration to
individual or groupa

Feed
Feed
Feed

Individual or group

Diseased animals
Diseased individuals; in
groups, may include
some animals that are
not diseased or are
subclinical
Some
None evident, although
some animals may be
subclinical
None
None
None

Adapted from McEwen and Cray. (140)
Food animals are usually grouped by pen, flock, pond, barn, or other aggregate.

13

1. Antibiotic Use and Resistance Associated with Swine
USDA NAHMS data provide some indication of the prevalence of antibiotic use
in US swine production (214). It was found that 92% percent of farms surveyed had used
antibiotics in the six-month period prior to the survey, with most being delivered through
the feed. More than 85% of sites used in-feed antibiotics in the grower/finish phase. Most
commonly used were tylosin, chlortetracycline, and bacitracin, with 56%, 43%, and 35%
of sites using each, respectively. However, recent changes in the swine industry, a
growing awareness of issues surrounding nontherapeutic uses of antibiotic products, and
changing trends in therapeutic and nontherapeutic regimens may have caused a change in
the overall use of antibiotics in more recent times, particularly in grower/finisher units
and in high health herds where advantages of extended antibiotic use are less easily
demonstrated (51, 64)
Through applied studies, a link between antibiotic use in swine and increased
prevalence of resistant bacteria can be clearly demonstrated (133, 134). While such
studies have shown significant increases of antibiotic resistance in the gut flora following
use of antibiotics, it has also been shown that rapid reversion to susceptibility in
commensal microflora following drug withdrawal may also occur, depending upon drug
type. Studies with the aminoglycoside drug apramycin have shown that the general
population of fecal E. coli demonstrate an increase in apramycin resistance soon after
initiating the use of that antibiotic; however, this increase was followed by a return to
more normal susceptibility when the drug was withdrawn (134, 135). As such, and as this
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antibiotic was used exclusively in young pigs, the impact of apramycin use would appear
to be minimal with regard to resistance of E. coli in market animals.
A study conducted by Gellin et al. (81) examined antibiotic resistance in
experimental swine herds and found that 36.4%, 74.3% and 99.6% of E. coli isolates
obtained from a herd regularly exposed to antibiotics were resistant to ampicillin,
streptomycin and tetracycline, respectively. The same study examined resistance levels
in E. coli isolated from a different herd that had not been exposed to antibiotics in over 50
weeks and found that only 0.5%, 12.4% and 26.7% of isolates were resistant to those
same antibiotics, respectively. Another study by Mathew et al. (136) showed that 98%,
64.4%, 86%, and 29% of E. coli isolated from commercial swine farms where antibiotics
were used extensively were resistant to tetracycline, neomycin, gentamicin, and
apramycin, respectively, by the time pigs reached 63 days of age.
2. Antibiotic Use and Resistance Associated with Poultry
Antibiotics are used in the poultry industry for therapeutic, nontherapeutic and
growth promotion (55, 129). Growth promoting antibiotics used in US poultry production
include chlortetracycline, bacitracin, bambermycin, tylosin, and virginiamycin (55).
Bacterial diseases, including colibacillosis, enteritis caused by Clostridium spp.,
mycoplasmosis, and several forms of salmonellosis, cause significant economic loss to
the poultry industry (20, 88) and are a primary reason for treatment with antibiotics (196).
Common antibiotics used for control of these organisms include sulfonamides,
amoxicillin, tetracyclines, tylosin, virginiamycin, neomycin, and penicillin. Until
recently, enrofloxacin, a fluoroquinolone drug, was approved for control of colibacillosis;
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however, concerns that fluoroquinolone use in poultry may be linked to antibioticresistant Campylobacter infections in humans (39, 148, 166) caused the FDA to ban the
use of that drug in poultry in 2005 (75).
NARMS data indicate that Salmonella from chickens have demonstrated
increased resistance to amoxicillin/clavulanic acid, ceftiofur, cefoxitin and tetracycline
since the NARMS program was initiated (151). In 1997, 0.5% of slaughter isolates were
resistant to amoxicillin/clavulanic acid, 0.5% were resistant to ceftiofur, 0% were
resistant to cefoxitin, and 20.6% were resistant to tetracycline. Preliminary data from
2005 indicate that 12.1%, 12.2%, 12.0% and 28.3% of Salmonella isolates from poultry
at slaughter were resistant to those same antibiotics, respectively. A slight increase in
resistance to ampicillin was noted over that same time period, whereas little or no change
was noted for resistance to chloramphenicol, ciprofloxacin, kanamycin, and
streptomycin. Marked decreases have occurred for resistance to gentamicin and sulfa
drugs over that same time period. In 1997, 17.8% and 24.8% of isolates were resistant to
gentamicin and sulfamethoxazole; whereas in 2005, 4.3% and 8.5% were resistant to
those same drugs, respectively.
Cui et al. (54) conducted a study comparing prevalence and resistance of bacteria
from conventionally raised chickens to organically raised chickens in Maryland. In that
study, all Salmonella isolates derived from conventionally raised birds were resistant to 5
or more antibiotics, whereas 79% of isolates from organically raised birds were sensitive
to all 17 antibiotics tested. However, as isolates were derived from poultry products of
retail markets, it is unknown what effects, if any, were the result of processing location or
methods. Harwood et al. (97) observed vancomycin resistant Enterococcus (VRE) from
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chicken feces, and from hospital waste water, but not from dogs, cattle, pigs, wild birds,
raccoons feces, or surface water from 3 main waterways in Florida; however, the sources
of chickens and other animals were not described.

In that study, Enterococcus spp.

resistant to “low” concentrations of vancomycin (3 µg/ml) and harboring the vanC gene
were isolated from chickens. By comparison, VRE (E. faecium and E. avium) resistant to
“high” levels of vancomycin (10 µg/ml) and harboring the vanA gene were readily
isolated from hospital waste water. Two Enterococcus isolates from chicken feces that
were resistant to high levels of vancomycin were identified as E. gallinarum.
Fairchild et al. (74) investigated effects of tetracycline administration on cecal
commensal bacteria, Enterococcus spp., E. coli and Campylobacter spp. They observed
that Enterococcus spp. and E. coli, resistant to tetracycline and harboring a number of
different tetracycline resistance genes were readily isolated in chickens, regardless of
exposure or non-exposure to that drug. Tetracycline treatment in test birds did not
produce tetracycline resistance in Campylobacter spp. in their study; however,
tetracycline-resistant Campylobacter spp. were readily isolated from flocks that received
and did not receive that antibiotic. The investigators concluded that complex population
dynamics and genetics in enteric bacterial populations contributed to the antibiotic
resistance observed in commercial flocks.

Risks Posed to Humans by Antibiotic Use in Livestock
It has been well established that agricultural use of antibiotics results in increased
prevalence of antibiotic-resistant bacteria in farm environments, thus contributing to the
global pool of antibiotic resistant organisms. However, what risks this poses to human
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health has not been clearly established. Foodborne transfer of bacteria carrying resistance
genes is the most likely route through which agricultural use of antibiotics could affect
human health. However, some evidence for direct animal to human transmission of
antibiotic resistant bacteria has been reported (27, 102, 103, 111).
Beyond selection for antibiotic resistant bacteria, there have been some concerns
that on-farm use of antibiotics may also increase pathogen load in animals by selecting
for pathogens that are known to possess antibiotic resistant genes, integrons, or genetic
islands containing resistance genes. These organisms may have an advantage under the
selective pressure of antibiotic use, aiding in their colonization, which could then result in
a greater pathogen load. A frequently cited study supporting this hypothesis is that of
Williams et al. (231). Using swine infected with a chlortetracycline-resistant strain of S.
Typhimurium, they showed that subsequent treatment of infected pigs with
chlortetracycline increased both the quantity and duration of shedding of that challenge
organism. However, several subsequent studies have failed to show that antibiotic use
caused increased pathogen loads, and following an extensive review of the literature the
US Food and Drug Administration determined that no evidence existed to support the
need for pathogen load analysis as a part of their Guidance Document # 152 FDA-CVM
(76). In fact, some studies have shown that antibiotic use in livestock reduced shedding of
foodborne pathogens (68, 87, 123).
There are several confounding factors that make the assessment of the risks posed
by agricultural use of antibiotics difficult. A primary difficulty is that a large number of
the antibiotics used in livestock production are also used in human and pet medicines,
thus presenting difficulties in determining the initial sources or reservoirs for the resistant
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populations. For example, it would be difficult to assign blame for the increase in
sulfonamide resistance to use of sulfa drugs in livestock when sulfonamides have been
used extensively in humans for prevention of acne, urinary tract infections, and diarrhea,
among other common uses (95, 215). Cross resistance within and across families of
antibiotics is also a confounding factor, as some antibiotics used solely in human
medicine can select for resistance to other drugs which may be used primarily in
livestock, and vice versa. As indicated earlier, broad mechanisms of resistance, such as
efflux pumps, may be increased by use of a single antibiotic, but may subsequently
confer resistance to unrelated antibiotics, making it difficult to determine the initial agent
of selection. The fact that antibiotic resistance develops from both therapeutic and
nontherapeutic use (81, 119) presents some additional difficulty in establishing a point
from which to consider risks. Risk assessments focusing on nontherapeutic uses, the
primary concern of agricultural use, would likely be confounded by resistance selection
caused by therapeutic uses commonly applied for chronic diseases. It follows then that
elimination of veterinary use of some antibiotic products may not translate into
reductions of some antibiotic resistance patterns in bacteria of concern.
Some efforts have been undertaken to model antibiotic resistance and determine
quantitative or semi-quantitative risks associated with agricultural use of antibiotics (19,
222). Such efforts have been conducted using defined risk assessment approaches, as
opposed to precautionary principle approaches, for assessment and development of
control strategies (223). However, the current lack of numerical or empirical data in key
areas has hampered those efforts and/or caused some to doubt the validity of such risk
assessments. Still, these attempts have indicated that direct risks of on-farm antibiotic
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use may not be as significant as originally projected, primarily due to low risk elements
in the steps between the movement of resistant organisms off of farms and the projected
failure of a human therapy as a result of the agricultural use (50, 105). As an example,
Hurd et al. (105) conducted a semi-quantitative risk assessment of the potential impact of
using the macrolide antibiotics tylosin and tilmicosin in the various livestock
commodities. The analysis was conducted based on guidelines outlined in the Guidance
for the Industry Document #152 (76). In that analysis, it was conservatively assumed that
all occasions of tylosin and tilmicosin use in pigs or poultry would lead to macrolideresistant bacteria, including S. enterica serovars, Campylobacter spp. and E. faecium; and
that those bacteria would contaminate meat and poultry products, causing foodborne
illness at rates cited by CDC FoodNet data. However, as human foodborne illnesses
caused by those organisms are seldom, if ever, treated with macrolide antibiotics, the risk
of failure of a macrolide-mediated antibiotic therapy was negligible. In the analysis, the
overall risks for consumption of poultry, swine and beef were estimated to be 1 in 14
million, 1 in 53 million, and 1 in 236 million cases per year in the US, respectively, for
Campylobacter (combined risk C. coli and C. jejuni), and 1 in 3 billion, 1 in 21 billion,
and 1 in 29 billion cases per year in the US, respectively, for E. faecium.
comparison,
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Campylobacter attributed to the consumption of chicken, estimated the risk at 1 in 32,900
cases, and determined this level of risk to be “low” (77). Using similar techniques, Cox
and Ricci (49) estimated that a ban on enrofloxacin use in poultry would prevent less than
1 severe incident per year in the US, while causing approximately 6,600 additional cases
of campylobacteriosis and more than 40,000 excess illness days.
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The Origin of Antibiotic Resistance
It well known that a number of bacterial and fungal species possess the ability to
produce antibiotic compounds, typically to gain a competitive advantage in
microorganism-rich environments, including soils and biofilms (8). It is likely then that
naturally-occurring antibiotics were present in the environment long before the first
antibiotic agents were introduced into clinical use (189). Many antibiotic products used in
human and animal medicine today have their origins in antibacterial compounds
produced by organisms such as Streptomyces, Bacillus, Penicillium, Cephalosporium and
Pleurotus. As researchers have been able to identify those compounds and their active
components, development of more potent analogs has been possible (190).
Antibiotic resistance likely also emerged in nature prior to human use of drugs as
organisms producing antibiotic compounds required the means to survive in the presence
of their own products, and competing species also found ways to counteract effects of
those compounds (59). Thus, some antibiotic resistance genes likely originated long
before the advent of man, modern medicine, and agricultural use of antibiotics. TrieuCuot et al. (212) have shown that resistance to kanamycin due to aminoglycosidephosphotransferase-3’ developed in antibiotic-producing bacteria Bacillus circulans and
Streptomyces fradiae as a mechanism of self-protection. The ancestor gene of erm genes,
responsible for macrolide antibiotic resistance, was implicated in erythromycin resistance
in antibiotic–producing strains of Streptomyces erythreus and Arthrobacter as well as in
Gram-positive cocci and bacilli bacteria (15). Some aminoglycoside–inactivating
enzymes, responsible for aminoglycoside resistance, appear to have originated from
aminoglycoside-producing bacteria, such as Streptomyces, Micromonospora, and
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Bacillus (58, 117, 194). The genes, encoding ribosomal protection proteins mediating
tetracycline resistance and found in pathogenic and saprophytic organisms, show high
similarity to genes found in tetracycline-producing strains. (9). As indicated by many
researchers, sensitive microorganisms can gain resistance to antibiotic agents by directly
or indirectly acquiring these resistance genes from antibiotic-producing organisms. For
example, D’Costa et al., (56) suggest that soil microbes provide a large reservoir of
antibiotic resistance genes that can be quickly mobilized into other microbial
communities, including enteric bacteria and pathogens, under the selection of antibiotic
use. Benveniste and Davies (23) suggested that dissemination of antibiotic resistance
genes has been accelerated due to the presence of bacterial DNA, carrying resistance
genes in antibiotic preparations. Other research using PCR amplification of known
resistance genes, demonstrated that contaminating DNA from Streptomyces spp. used in
industrial production of antibiotics, resulted in a source of antibiotic resistance genes in
commercial antibiotic preparations (226). When the resistance genes are transferred
across species or genus of bacteria, they may undergo mutation in their new host
resulting in a wide variety of differences in structural but similar functional resistance
determinants (189). The evolution of efflux proteins associated with tetracycline
resistance in both Gram-negative and Gram-positive bacteria is frequently cited as an
example of such divergent mutation (177). The stepwise mutation of genes whose
product plays a role in physiological cell metabolism is another way for the bacteria to
develop resistance properties. The substrate spectrum of the gene products will change
from metabolite of biosynthesis or biodegradative pathways to certain antibiotic agents
only (189). The enzymes exhibiting acetyl-, adenyl- or phosphotransferase activities that
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inactivate aminoglycosides or chloramphenicol are believe to have evolved through this
mechanism (108).

Modification of target structure is also a way that bacteria become

resistant to antibiotic agents. This modification can occur either by single-step, e.g. in
streptomycin resistance, or multiple-step, e.g. in fluoroquinolone resistance (7). As
antibiotic use became commonplace in human medicine and food animal production,
selection pressure increased the advantage of maintaining resistance genes in diverse
groups of bacteria, and bacterial evolutionary progress eventually included mechanisms
to retain, accumulate and disperse resistance genes among bacterial populations (1)
(Figure 1).
Among the first reports to suggest that antibiotic use in livestock promoted
resistance was that of Starr and Reynolds (200) who noted streptomycin resistance in
coliform bacteria from turkeys that had been fed that antibiotic.

Other researchers

reported the association of resistance to antibiotics in fecal streptococci when growthpromoting levels of tetracycline were fed to chickens (70). Since that time, numerous
studies have demonstrated a link between antibiotic use in livestock and increased
prevalence of antibiotic resistant organisms associated with those animals, the farm
environment, and in some cases agricultural products (140, 232, 233).

The Debate over Antibiotic Use in Livestock
With concern over antibiotic resistance growing, a number of organized
deliberations on the issue began to occur, including that of the Netherthorpe Committee
(47) and the Swann Committee (204). Both groups focused specifically on antibiotic use
in food animals, and came to different conclusions regarding the risk of such to human
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Figure 1. The emergence of antimicrobial resistance. Possible pathway depicting the
emergence and transfer of antimicrobial resistance and/or antimicrobial resistant bacteria.
Adapted from McDermott et al. (139).
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Health. The Netherthorpe report concluded there was no evidence that agricultural use
posed a risk to humans, whereas the Swann Committee concluded otherwise and
indicated that the administration of antibiotics to livestock, particularly at nontherapeutic
levels, posed a significant hazard to human and animal health.

Among the

recommendations of the Swann Committee were that antibiotics used for livestock
production be available by prescription only and in-feed antibiotics should be limited to
100 ppm. Additionally, the Committee recommended that surveillance programs be
established to monitor antibiotic resistance in bacteria of concern. The Swann report
spawned much debate among the scientific community, as some noted the findings were
partly based on anecdotal evidence and/or studies with little scientific rigor, and in some
cases were more presumptive than substantive. This debate resulted in an increase in
studies to investigate the issue of antibiotic use in livestock and risks associated with such
use.
Over subsequent decades, other organizations became active in the debate.
Among some of the most notable was the American Society of Microbiology (ASM)
which formed the Task Force on Antibiotic Resistance, consisting of scientists from
academia, the government and industry. Their initial report focused on critical issues and
risks posed by the widespread and growing use of antibiotics in human medicine and
agricultural production. That report provided a comprehensive set of recommendations
for surveillance programs, as well as recommendations to address emerging resistant
organisms and the development of new drugs and non-antibiotic therapies (16). In 1997,
the World Health Organization (WHO) released a report that provided a strong statement
against the use of antibiotics for growth enhancement, indicating that such use is
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particularly conducive to selection for resistant bacteria (229). Later reports included the
WHO Global Principals for the Containment of Antibiotic Resistance in Animals
Intended for Food, which was formulated jointly with the Office of International des
Epizooties (OIE) and the United Nations Food and Agricultural Organization (FAO)
(230). That document, which was intended to provide a framework of recommendations
to reduce the overuse and misuse of antibiotics for the protection of human health,
outlined recommendations for pre-approval, manufacturing, distribution, sales, and
prudent use of drugs, surveillance of resistance, and education of veterinarians and
producers regarding use and hazards of food animal antibiotics.

The report also

recommended that in the absence of risks assessments, growth promoting antibiotics that
are also used in human medicine should be rapidly phased out, preferably through
voluntarily programs, but if necessary, by legislation. In 2002, the American Academy
of Microbiology, representing the highest leadership within ASM, issued a report titled
The Role of Antibiotics in Agriculture (106). Among the recommendations of that report
were a call for better estimates of antibiotic use in livestock and aquaculture production,
the need for research into the economics of growth promoting antibiotics, a call for wider
dissemination and education of judicious use principles among veterinarians and
producers, and more research into reservoirs of resistance, resistance transfer, and
quantitative risks assessments.
During the same period, US agencies also addressed the issue of antibiotic
resistance. In 1997, surveillance, educational and research initiatives to address antibiotic
resistance in foodborne pathogens were expanded through funds provided by the
President’s Food Safety Initiative (210).

In 1999, an interagency Task Force on
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Antibiotic Resistance was formed, headed by the Centers for Disease Control (CDC), the
National Institutes of Health (NIH), and the FDA. In 2001, the Task Force released the
Public Health Action Plan to Combat Antibiotic Resistance, with the main aspects to
include surveillance, prevention and control, research, and product development related
to antibiotic resistance (37). Since its initiation, the Task Force continues to expand in
scope, and partner with other national and international agencies, addressing high priority
issues relevant to antibiotic resistance (36). Soon after establishment of the Task Force,
the FDA directly addressed the issue of risks caused by use of antibiotics in food animals
with the release of the Guidance for Industry #152, which outlined steps for risk
assessments for the evaluation of new animal drugs in terms of microbial food safety
(FDA, 2003). While not mandated, the steps suggested by Guidance #152 have provided
clear direction for pharmaceutical companies to assess the potential for emergence and
selection of antibiotic resistant foodborne pathogens as a result of the drug use. Table 2
shows reports addressing the association of antibiotic use in food animal and public
health.
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Table 2. Report on the use of antibiotics in animals and associated public health
implication. 1
Year

Report (Source)

1969

Swann Committee Report (Joint Committee on the Use of Antibiotics in
Animal Husbandry and Veterinary Medicine)
The Use of Drug in Feed animals (National academy of Sciences)
The Use of Antibiotic in Animal Feeds (FDA task force)
Need to Establish Safety and Effectiveness of Antibiotic Used in Animal
Feeds (U.S. General Accounting Office Report)
Drugs in Livestock Feed (Office of Technology Assessment)
The Effects on Human Health of Subtherapeutic Use of Antibiotic in
Animal Feed (Institute of Medicine Report)
Antibiotic in Animal Feeds (Council for Agricultural Science and
Technology)
Human Health Risks with the Subtherapeutic Use of Pennicillin or
Tetracyclines in Animal Feed (Institute of Medicine Report)
Impacts of Antibiotic-Resistant Bacteria (Office of Technology
Assessment)
The Medical Impact of the Use of Antibiotic in Food Animals (World
Health Organization)
Antibiotic Feed Additives (Ministry of Agriculture, Commission on
Antibiotic Feed Additive)
Fluoroquinolone Use in Food Animals (World Health Organization)
A Review of Antibiotic Resistance in the Food Chain (Ministry of
Agriculture, Fisheries, and Food)
Use of Drug in Food Animals: Benefits and Risks (National Research
Council)
The Agricultural Use of Antibiotics and its Implications for Human Health
(U.S. General Accounting Office Report)
The Use of Antibiotics in Food-Producing Animals: Antibiotic-Resistant
Bacteria in Animal and Humans (Joint Expert Advisory Committee on
Antibiotic Resistance)
Opinion of the Scientific Committee on Animal Nutrition on the Criteria
for Assessing the Safety of Microorganism Resistant to Antibiotics of
Human Clinical and Veterinary Importance (EU SCAN Report)
Risk Assessment on The Human Health Impact of Fluoroquinolone
Resistant Campylobacter Associated with the Consumption of Chicken
(Center for Veterinary Medicine)
The Need to Improve Antibiotic Use in Agriculture: Ecological and
Human Health Consequences (The FAAIR Report)

1969
1972
1977
1979
1980
1981
1989
1995
1997
1997
1998
1998
1998
1999
2000
2001
2001
2002
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Table 2. (continued) Report on the use of antibiotics in animals and associated public
health implication.
Year

Report (Source)

2002

Uses of Antibiotic in Food Animal in Canada: Impact on Resistance
and Human Health (Health Canada Advisory Committee on Animal Uses
of Antibiotics and Impact on Resistance and Human Health)
Food Safety and Pig Production in Denmark: controls on Antibiotics,
Veterinary Medicines and Salmonella (Verner Wheelock Associates
Limited; Danish Bacon and Meat Council)
Joint FAO/OIE/WHO Expert Workshop on Non-Human Antibiotic
Usage and Antibiotic Resistance: Scientific Assessment (World
Health Organization)
Impact of Antibiotic Growth Promotion Termination in Denmark
(World Health Organization)

2002
2003
2003

1

Compiled from Prescott (171), and McDermott et al. (228).
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II. ANTIBIOTIC ACTIVITIES AND MECHANISMS OF
ANTIBIOTIC RESISTANCE DEVELOPMENT AND TRANSFER

Antibiotic Targets and Mechanisms of Action
Most antibiotics target bacterial structures and metabolic pathways that are
essential for bacterial growth, survival, or both, while causing little or no effect to
eukaryotic hosts harboring the bacteria. Antibiotics interfere or block the growth of
bacteria by binding to specific target sites in or on bacteria forming a complex structure
that no longer displays the original functions. The four principle targets for the main
classes of antibiotic are: 1) bacterial cell-wall biosysnthesis; 2) bacterial protein
synthesis; 3) bacterial DNA replication; and 4) folic acid synthesis.
1. Inhibition of Cell Wall Synthesis
The cell wall is an essential structure of bacteria because it confers mechanical
protection and provides a solid surface for protein and appendages necessary for cell
adhesion, motility, host infection, and horizontal gene transfer (84). The bacterial cell
wall differs from that of all other organisms by the presence of peptidoglycan (poly-Nacetylglucosamine and N-acetylmuramic acid), which is located immediately outside of
the cytoplasmic membrane. There are two main types of bacteria, Gram-positive and
Gram-negative, according to their cell walls components. Gram-positive organisms are
characterized by the presence of a thick peptidoglycan layer, while Gram-negative
organisms contain a thin peptidoglycan but have an additional outer membrane composed
by phospholipids and lipopolysaccharides. Multiple enzymes are required for
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peptidoglycan synthesis and attachment to the cell wall. Enzymes involved in the final
stage of cell wall synthesis are called transpeptidases. Beta-lactam antibiotics (penicillins,
cephalosporins, and other classes used in human medicine, such as carbapenems and
monobactams) bind to transpeptidases and inhibit peptidoglycan formation, thus
interfering with cell wall synthesis. Glycopeptide antibiotics, including vancomycin,
teicoplanin, and the growth promoter avoparcin, inhibit cell wall synthesis by forming a
complex with residues of peptidoglycan precursors, making it inaccessible to
transpeptidase. (24, 84, 153, 175).
2. Inhibition of DNA Replication
DNA replication is a vital function of the bacterial cell. DNA gyrase and DNA
topoisomerase IV are enzymes that control the folding or supercoiling of the DNA during
DNA replication. They are essential for preventing the DNA molecule from becoming
entangled during replication of circular chromosomes in bacteria. Quinolone antibiotics
irreversibly bind to the DNA molecule-gyrase complex, thereby preventing DNA
replication and leading to bacterial cell death. The original quinolone was naladixic acid,
which only acts on aerobic Gram-negative species. The newer fluoroquinolones, such as
ciprofloxicin, norfloxacin, and ofloxacin, have a much broader spectrum of activity (84,
153).
3. Inhibition of Protein Synthesis
Proteins play an essential role in bacterial cells since enzymes and most cellular
structures are composed of protein. Protein synthesis consists of two biological processes
starting with transcription of DNA to mRNA and translation of mRNA into protein.
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Several classes of antibiotics inhibit protein synthesis by acting on the ribosome during
the translation process. Bacterial ribosomes contain two subunits, the 50S and 30S
subunits. Antibiotics bind to one or both subunits, and cause misreading of the genetic
code or formation of abnormal, nonfunctional protein complexes. Aminoglycosides
(gentamicin, tobramycin, amikacin, streptomycin) and tetracyclines are antibiotic classes
that act primarily by binding to the 30S subunit. Tetracyclines are bacteriostatic rather
than bactericidal because their binding to the ribosome is transient. Several other classes
of antibiotics inhibit the 50S ribosomal subunit. Macrolides (erythromycin, tylosin,
tilmicosin), chloramphenicol and clindamycin are primarily bacteriostatic and attach
reversibly to the 50S subunit and interfere with the linking of amino acids (84, 153).
4. Inhibition of Folic Acid Synthesis
Folic acid is an essential precursor of pyrimidine rings in nucleic acids; therefore
inhibition of folic acid synthesis will result in indirect inhibition of nucleic acid formation
and function. Unlike humans and animals, bacteria usually lack the ability to take up folic
acid from the environment and must synthesize it internally. Sulfonamides and
diaminopyrimidine (trimethoprim and similar compounds) interfere with folate
metabolism by competitively and irreversibly binding to dihydrofolate synthase or
dihydrofolate reductase, two enzymes necessary for production of tetrahydrofolate.
Trimethoprim and sulfonamides are usually administered together because they display a
synergic therapeutic effect (84, 153).
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Mechanisms of Antibiotic Resistance Development and Transfer
The two most commonly used criteria to describe antibiotic resistance are based
on microbiological (in vitro resistance) and clinical (in vivo resistance) factors (84). For
the microbiological definition, a strain is defined as resistant if it is no longer inhibited by
the minimal concentration of the antibiotic that inhibits growth of typical strains of that
species (83). However, for clinical definitions, a strain can be defined as resistant when it
survives under chemical therapy. Under these conditions, a strain may be either sensitive
or resistant depending on its location, the dosage and the mode of drug administration,
tissue distribution of the drug, and the immune status of the patient (84).
Antibiotic susceptibility can be tested under laboratory conditions by exposing a
known concentration of bacterial culture to increasing concentrations of a select
antibiotic drug. These testing methods can be performed based on one of the three
approaches: broth microdilution, agar dilution, and agar diffusion (228). The endpoint
measurement based on inhibition of bacterial growth, is reported either qualitatively
(sensitive, intermediate, resistant) or quantitatively as minimum inhibitory concentration
(MIC), which is the lowest drug concentration that completely inhibits growth of the
bacterial isolate under test (114, 228).
Two aspects are typically discussed regarding antibiotic resistance. One is the
mechanism(s) by which the bacteria become resistant. The other is the development and
spread of antibacterial resistance genes. The following will discuss these two aspects in
detail.
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Mechanisms of Bacterial Antibiotic Resistance
Bacterial cells use several mechanisms to resist the effects of antibiotics. The
most widespread mechanisms are modification or replacement of the drug targets,
enzymatic drug inactivation, active drug efflux and reduced drug uptake. Other
mechanisms, including drug protection and overproduction of the drug’s targets, are less
common (Figure 2) (84, 153, 206).
1. Modification or Replacement of Drug Targets
By modification or replacement of the target receptor, the antibiotic no longer
binds and therefore does not have the intended effect. Target modification can be linked
to resistance mechanisms for almost all classes of antibiotics. This mechanism has been
known to be of importance for resistance to penicillin, glycopeptides, and macrolides
lincosamides and streptogramins (MLS) in Gram-positive bacteria, and for resistance to
quinolones in both Gram-positive and Gram-negative bacteria. Methylation of the drug’s
target, the ribosome (MLS and aminoglycoside resistance) and gene mutation of the
drug’s targeted bacterial enzyme in quinolone resistance are examples of target
modification. Glycopeptide resistance in enterococci and methicillin resistance in
Staphylococcus aureus are examples of replacement of drug target with a compound of
lower affinity (84).
2. Enzymatic Drug Inactivation
Enzymatic inactivation is the main mechanism that bacteria use to escape the
effect of β-lactams, aminoglycosides, and phenicols. Although not prevalent, these
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Figure 2. Mechanisms of antibiotic resistance development.
A) Target modification. B) Target protection. C) Drug trapping. D) Enzymatic drug
inactivation. E) Reduced permeability. F) Active efflux. Adapted from Guardabassi and
Courvalin (84).
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mechanisms are also known to be involved in resistance to tetracycline, MLS, and
fosfomycin. Enzymes can modify the active site of the drug by cleaving the molecule or
adding chemical groups that prevent the drug from binding to its target site, resulting in
the loss of antibacterial ability. The most important drug-inactivating enzymes are βlactamase and aminoglycoside-modifying enzyme. β-lactamase destroys beta-lactam
antibiotics before they reach the bacterial target, preventing it from binding to its target.
Aminoglycside-modifying enzymes function by catalyzing transfer of the acetyl group to
amino groups or phosphoryl groups or nucleotides to amino or hydroxyl groups in the
aminoglycoside molecule, resulting in poor binding of this drug to ribosome. (17, 84,
186)
3. Drug Efflux Pumps
By actively pumping out antibiotic molecules, drug efflux systems prevent the
intracellular accumulation necessary for antibiotics to exert their lethal activity. Drug
efflux pumps are energy-dependent mechanisms. These pumps may be specific for one
substrate (drug specific resistance pumps) or may transport a range of structurally
dissimilar compounds, including antibiotics of multiple classes, imparting multiple drug
resistance (multiple drug resistance pumps). Drug specific resistance pumps are the most
important mechanism of resistance to tetracycline. These pumps generally confer a high
level of resistance and are mostly associated with mobile genetic elements. Multiple drug
resistance pumps may have several substrates, however these pumps generally confer
low-level resistance and are usually encoded on the chromosome (84, 120, 227).
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4. Reduced Drug Uptake
Reduced drug uptake is another mechanism the bacteria use to reduce
concentrations of drugs accumulating in the cell. This may occur through several
mechanisms such as reduced outer membrane permeability, as in Pseudomonas
aeruginosa and E. coli O157:H7, porin mutation that leads to loss, reduced size, or
decreased expression of porin proteins, as in reduction of OmpF porin expression, which
has been shown to increase resistance of E.coli to quinolones, β-lactams, tetracyclines
and chloramphenicol. Lack of an electrical potential gradient, which is required to drive
the drug across the bacterial membrane, as in the case of aminoglycoside resistance, is
also a way that reduced drug uptake by bacteria can result (69, 84, 132)
5. Target Protection
Target protection has been reported to be involved in resistance to tetracyclines
and quinolones. Resistance to tetracyclines by this mechanism results from the presence
of ribosomal protection proteins. At least eight ribosomal protection proteins have been
found to be associated with tetracycline resistance. Among them, Tet(M) and Tet(O) are
the most prevalent and well-studied. The presence of a DNA gyrase protection protein
has been reported in quinolone resistant Enterobacteriaceae (48, 84, 85, 118, 211).
6. Drug Trapping
Bacteria can trap the drug by over production of the drug target or other molecule
with high affinity for the drug. Over production of targets for sulfonamides and
diaminopyrimidine have been reported in several bacterial species. A mutation resulting
in the thicker cell wall with many binding sites for vancomycin has been shown to trap
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antibiotic molecules, thereby reducing the number of vancomycin molecules that reach
the cytoplasmic membrane where the transglycosylase targets are located (18, 53).

Families of Antibiotics
Antibiotics can be grouped based on mechanisms of action but more often by
chemical structure. Antibiotics of the same chemical structure usually share many
biological properties making this classification of antibiotics useful in practice. Below are
descriptions of major antibiotic families, their modes of action, and mechanisms bacteria
employ to resist them.
1. β–Lactams
β-lactams comprise a family of bactericidal antibiotics that contain a β-lactam
ring in their structure. The principle antibiotics of this family include penicillins,
cephalosporins, carbapenems and monobactams. The β-lactam ring inhibits bacterial cell
wall synthesis by disruption of peptidoglycan cross-linkage; therefore these antibiotics
tend to be more active against Gram-positive bacteria which have a high concentration of
peptidoglycan in their cell wall. The spectrum of the penicillin family varies. Some
penicillins, such as Benzyl penicillin (Penicillin G) and phenoxymethyl penicillin
(Penicillin V), have a narrow spectrum, with activity against aerobic and most anaerobic
Gram-positive bacteria. Others, such as ampicillin and amoxycillin, have a broader
spectrum of activity against a range of Gram-positive and Gram-negative bacteria.
Cephalosporins are usually classified as generations, according to their antibiotic
properties. First-generation cephalosporins are predominantly active against Gram38

positive bacteria, and successive generations have increased activity against Gramnegative bacteria. Fourth generation cephalosporins, have true broad spectrum activity
active against Gram-positive and Gram-negative bacteria. Carbapenems have the
broadest antibacterial spectrum compared to penicillins and cephalosporins (25, 32, 88)
Bacteria can become resistant to β-lactam antibiotics by expressing betalactamase enzymes that degrade the β-lactam ring. Resistance to β-lactam drugs is not
only found in food-associated pathogens but also in commensal bacteria and it occurs in
bacteria of both animals and man. The widespread occurrence of bacteria carrying βlactamases is well documented around the world (13, 40, 98, 121, 145, 176, 179).
2. Aminoglycosides
Aminoglycosides are bactericidal antibiotics that include amikacin, gentamicin,
kanamycin,

neomycin,

netilmicin,

paromomycin,

streptomycin,

spectinomycin,

tobramycin and apramycin. These antibiotics usually contain a cyclic nucleus with one or
two amino acids attached by glycosidic linkages. The aminoglycosides interfere with
protein synthesis by binding to the 30S ribosomal subunit.

Aminoglycosides are

primarily active against aerobic bacteria, especially Gram-negative organisms such as
Salmonella, E. coli, and Pasteurella. They are also active against Pseudomonas and
Staphylococci. In addition, some mycoplasma, and some spirochetes are susceptible to
aminoglycosides (30, 88, 172).
Resistance to aminoglycosides usually occurs via enzymatic modification. The
majority of the enzymes that promote such are acylases or acetylases which modify the
conformation of the aminoglycosides thereby preventing them from binding to
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ribosomes.

Resistance

to

some

aminoglycosides,

such

as

streptomycin

and

spectinomycin, is widespread and the genes responsible for resistance to these antibiotics
are often found as gene cassettes carried in integrons (38, 82, 115, 147, 157).
3. Tetracyclines
Tetracyclines are a large family of broad spectrum antibiotics including
tetracycline, oxytetracycline, chlortetracycline and doxycycline. Tetracyclines are named
for their four hydrocarbon rings. More specifically, they are defined as a subclass of
polyketides having an octahydrotetracene-2-carboxamide skeleton. Tetracyclines are
bacteriostatic. They work by binding to the 30S ribosome and inhibit the function of such
by blocking the binding steps of molecules needed to initiate the process of protein
synthesis (translation). They are active against wide variety of bacteria such as Grampositive Gram-negative aerobes and anaerobes, and show activity against mycoplasmas,
chlamydia, protozoa and ricketsia. The various tetracyclines have a similar spectrum of
activity; however, they are different in degree of lipid solubility and therefore absorption
and ability to cross membrane (14, 78, 88, 152).
Resistance to tetracyclines can occur by at least three mechanisms, including
enzymatic inactivation, efflux pumps, and ribosomal protection. Resistance to these
antibiotics is widespread in both animals and humans and is well documented (2, 5, 6, 31,
35, 99, 107, 128, 130, 191).
4. Sulfonamides
Sulfonamides are groups of antibiotics that contain sulfonamide in their structure.
They

include

sulfaodiazine,

sulfamethazine,

sulfadimidine,

sulfadimethoxine,
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sulfadoxine, sulfachloropyridazine, and sulfamethoxazone. Sulfonamides are often used
together with trimethoprim, or one of the other diaminopyrimidines, known as
potentiated sulfonamides. While both compounds on their own are bacteriostatic, the
combination of these two compounds provides a synergistic effect resulting in
bactericidal action. Sulfonamides interfere with the folic acid synthesis in bacteria
preventing multiplication of the bacterial cell. Sulfonamides are broad spectrum
antibiotics inhibiting both Gram-positive and Gram-negative bacteria, as well as some
protozoa such as coccidia; however, they are ineffective against obligate anaerobes (11,
88, 172).
As with tetracycline, resistance to sulfonamides is widespread in bacteria
associated with humans and animals (26, 71, 86, 207). Several studies have shown the
presence of sulfonamide resistance genes in class 1 integrons as part of the integron’s
conserved sequence, and these elements are known to be responsible for widespread
dissemination of this sulfonamide resistance (86, 125, 197, 209).
5. Quinolones and Fluoroquinolone
Nalidixic acid was the first quinolone developed in 1962. Second generation 4quinolones are a group of compounds that include as oxolinic acid, pipemidic acid and
cinoxacin. The quinolones have narrow spectrum activity, affecting only Gram-positive
bacteria. Third generation constructs of these compounds are classified as
fluoroquinolones,

which

are

broad

spectrum

bactericidal

drugs.

The

newer

fluoroquinolones, such as enrofloxacin and danofloxacin, are highly active against Grampositive and Gram-negative bacteria, including Salmonella, Pseudomonas and
41

mycoplasmas. The quinolones and fluoroquinolones inhibit bacterial growth by binding
to DNA gyrase and DNA topoisomerase IV, thereby inhibiting DNA replication and
transcription (88, 162).
Bacterial resistance to this group of antibiotics is most commonly due to alteration
of DNA-gyrase via mutation (gyr-A). Less common but perhaps more important for
Gram-positive bacteria, mutation occurs to topoisomerase IV (parC). Other mechanisms
of resistance occur via decreased drug entry or increased active transport out of cell (29,
101, 142).
6. Phenicols
Phenicols include chloramphenicol, florfernicol and thiamphenicol. They are
bacteriostatic; however may be bactericidal in high concentrations or when used against
highly susceptible organisms. Chloramphenicols inhibit protein synthesis by binding to
50S ribosomal subunit. They are broad spectrum antibiotics, active against a wide range
of Gram-negative and Gram-positive bacteria and also some chlamydia spirochetes, and
ricketsia (88).
Bacteria become resistant to chloramphenicol by becoming impermeable to the
drug or by producing an inactivating enzyme, chloramphenicol acetyltransferase (195,
218).
Antimicrobial resistance mechanisms for each antibiotic drug group are shown in
Table 3. Table 4 provides a list of drugs licensed by USDA for animal use. A listing of
antibiotics licensed in Thailand is not available (149).
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Table 3. Antimicrobial Resistance Mechanisms.1
Antimicrobial Group
Aminoglycosides
Gentamicin
Streptomicin
Kanamycin
B-lactams
Cephalothin
Cefoxitin
Ceftiofur
Cefquinome
Folate pathway inhibitors
Sulfonamides
Macrolide-lincosamide-streptgramin
Erythromycin
Lincomycin
Virginiamycin
Phenicols
Chloramphenicol
Florfenicol
Quinolones and fluoroquinolones
Nalidixic acid
Ciprofloxacin
Enrofloxacin
Tetracyclines
Chlortetracycline
Tetracycline
Doxycycline
1

Anitimicrobial Resistance Mechanism
Modifying enzymes
Decrease permeability
Target resistance (ribosome)
Efflux
Reduce permeability
Altered penicillin-binding proteins
B-lactamase, cephalosporinases
Efflux
Decrease permeability
Production of drug-insensitive enzymes
Decrease ribosomal binding
Decrease permeability
Modifying enzymes
Efflux
Decrease ribosomal binding
Decrease permeability
Modifying enzymes
Efflux
Target resistance(DNA gyrase, Topoisomerase IV)
Decreased permeability
Efflux
Target resistance (ribosome)
Drug detoxification
Efflux

Adapted from McDermott et al. (139).
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Table 4. Antibiotic drugs licensed for avian and porcine use in the US and of human
health importance. 1

Antibacterial class
Aminoglycosides

Aminocyclitols
Cephalosporins

Lincosamides
Macrolides
Penicillins
Phenicols
Pleuromutilins
Polypeptides
Quinoxalines
Streptogramins
Sulfonamides
Tetracyclines
Miscellaneous

1
2

Licensed drugs
Gentamicin
Streptomycin
Kanamycin
Neomycin
Apramycin
Spectinomycin
Narrow spectrum
Cefalexin
Expanded spectrum
Ceftiofur
Lincomycin
Erythromycin
Tylocin
Tilmicosin
Penicillin G and V
Ampicillin2
Amoxicillin2
Florfenicol
Tiamulin
Valnemulin
Bacitracin
Colistin
Carbadox
Second generation
Enrofloxacin
Virginiamycin
Many compound
Oxytetracycline,
chlortetracyclines,
tetracycline
Avilanycin
Bambermycin

Animal used

Human health
importance

Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Porcine
Avian and Porcine

High
Low
Medium
Rarely used
Not used
Low

Porcine

Medium

Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian
Avian and Porcine

Very high
High
High
Not used
Not used
Low
Medium
Medium
Not used
Not used
Not used
Very low
Low
Not used

Avian and Porcine
Avian and Porcine
Avian and Porcine
Avian and Porcine

Very high
High
Medium
Medium

Porcine
Porcine

Not used
Not used

Adapted from Guardabassi and Courvalin (84).
With or without the beta-lactamase inhibitor clavulanic acid.
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Resistance to Antibiotic Agents
Resistance to antibiotic agents can be subdivided into two groups, intrinsic
resistance and acquired resistance (190). Intrinsic resistance is a genus- or speciesspecific property of bacteria which describes the status of bacteria with regard to inherent
insensitivity to a particular antibiotic agent or class of agents (84, 190). Such may be due
to the lack of target for certain antibiotic agents (e.g. resistance to β-lactam by bacteria
that lack a cell wall), their inaccessibility in specific bacteria (e.g. impermeability to
glycopeptides by the outer membrane of Gram-negative bacteria), extrusion of the
antibiotic by chromosomally encoded active exporters (e.g. resistance to tetracyclines,
chloramphenicol, and quinolones in Psuedomonas aeruginosa), or innate production of
enzymes inactivating the drug (e.g. AmpC β-lactamase in some Enterobacteriaceae) (84).
Unlike intrinsic resistance, acquired resistance is a strain-specific property of a
particular bacterial genus or species. Acquired resistance is a major threat to human and
animal health because it results in the emergence and spread of resistance in normally
susceptible bacteria populations, and can consequently result in therapeutic failure (84,
190). Acquired resistance is the result of genetic change in the bacterial genome which
can occur by mutation of chromosomal target genes, or by horizontal acquisition of
foreign resistance genes (34). Mutations can occur spontaneously in any gene of the
bacterial genome during the replication of bacteria. The frequency of mutation and the
expression of an antibiotic resistance phenotype will depend on environmental factors,
cell physiology, bacterial genetics, and population dynamics (131). Although the rate of
mutation is low (in vitro rates of 10-6 to 10-12), it may be relatively common in the
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ubiquitous and vast bacterial population. The resistance caused by mutations plays an
essential role in bacteria that are not known to acquire foreign DNA under natural
conditions (such as Mycobacterium spp.). This is the major mechanism of acquiring
resistance when a high level resistance is not conferred by mobile genetic elements, as in
the case with fluoroquinolone resistance. (84). In many cases, different species or genera
of bacteria are found to contain closely related or even the same antibiotic resistance
genes, indicating the exchange of resistance genes by horizontal transfer. Such resistance
gene transfer events occur not only in pathogenic bacteria but also in harmless
commensal normal flora (190). Many antibiotic resistance genes are located on mobile
genetic elements, such as plasmids, transposons, and integrons, which can act as vectors
which promote gene transfer between bacteria (158).

Horizontal Gene Transfer Mechanisms
Antibiotic resistance genes located on plasmids, transposons, gene cassettes in
integrons, or genomic islands are spread vertically during division of host cells. However,
they can also transfer horizontally between the same or different species or genera of
bacteria through three main mechanisms: transformation, transduction, and conjugation
(Figure 3). Transformation occurs via uptake of exogenous DNA from the immediate
surrounding environments, which can be incorporated into naturally transformable
bacteria, and by bacteria which become competent for transformation under special
physical or chemical conditions (21, 178). Conjugation results from the transfer of
plasmids, which are typically exchanged between donor and recipient cells through
physical contact (234). Transduction is facilitated by bacteriophages, which inject their
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Bacterial chromosome

Free DNA

Phage

B
A

C

Antibiotic resistance genes
Plasmid

Figure 3. Three main mechanisms by which antibiotic resistance genes are
transferred horizontally among bacteria.
A) Transduction; bacteriophage containing bacterial genes transduce bacteria though
phage lytic cycle; B) Transformation: free DNA is taken up by bacterial cell and
incorporated into the genome through recombination; C) Conjugation: plasmid
containing antibiotic resistance genes is passed from donor to recipient bacteria through
pilus.
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DNA into the genome of a host bacterium, after which replication and re-packaging of
the bacteriophage DNA occurs. In that process, bacterial DNA may be incorporated into
the viral DNA and upon dispersion of new bacteriophages and injection of repackaged
DNA into new hosts, resistance genes from the original host may be disseminated into a
new population (66).
Transduction and transformation do not require viability of the donor cell nor the
simultaneous presence of donor and the recipient cell in a given environment (158).
However, since both mechanisms require homology between donor and recipient DNA
for recombination to occur, and the host range of transduction is limited by the high host
specificity of bacteriophage (60), the spread of antibiotic resistance via transduction and
transformation is limited to closely related bacteria belonging to the same species or
genus (184). As antibiotic resistance genes are often located on conjugative genetic
elements such as plasmids or transposons and these elements can maintain themselves in
the new hosts without requiring large regions of sequence similarity to integrate into the
new host’s genome, conjugation likely plays a more important role in dissemination of
antibiotic resistance genes across species and genus barriers (184, 185).

Elements Involved in Horizontal Transfer of Resistance Genes
Plasmids, transposons, integrons/gene cassettes, and chromosomal genomic
islands play major roles in horizontal transfer of antibiotic resistance genes (189). These
four types of elements are composed of double-stranded DNA, but differ distinctly in
their sizes, structures, biological properties as well as mechanisms of spreading (190).
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1. Plasmids
Plasmids are autonomously replicating extra-chromosomal elements that vary in
size from less than 2 kilobase pairs (kb) to more than 100 kb. Plasmids have been
detected not only in nearly all bacterial genera of clinical importance but also in normal
flora of the skin and various mucosal tissues in humans and animals. Plasmids code for
resistance to antibiotic agents, disinfectants, heavy metal cations, anions, nucleic acidbinding substances, or bacteriocins, providing mechanisms for the bacteria to survive
under environmental stress (190). Plasmids can also code for metabolic (22, 61) or
virulence properties (150, 170, 188, 235), allowing recipient bacteria to exist in new
environments or gain novel virulence properties. Resistance plasmids are known to carry
one or more resistance genes, sometimes in addition to genes for other traits. Large
plasmids can carry a tra gene complex that enables them to move from one host cell to
another by conjugation. Such plasmids are called conjugative plasmids.

In most

instances, the genes necessary for transfer are located together with resistance
determinants on the same plasmid, creating a highly efficient mechanism for antibiotic
dissemination among bacteria (113). The broad host-range, conjugative plasmids are
possibly the most active vehicle for a potential horizontal gene pool of antibiotic
resistance genes that are available to many bacteria of many species and families (158,
208). It is important to note that not every plasmid can replicate in every bacterium.
Therefore, when transferred into a new host cell, plasmids may stably replicate, cointegrate with other plasmids; or integrate, either in part or completely, into the
chromosomal DNA (190).

Plasmids usually act as vectors for transposons and
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integrons/gene cassettes, thus promoting rapid spread of multiple antibiotic resistance
genes (114).
2. Transposons
Since transposons do not possess replication systems, they must integrate into
chromosomes or plasmids to maintain their stability. Transposons also vary in their
structures and sizes ranging from less than 1 kb to 60 kb. The smallest type of transposon
is insertion sequence (IS), which usually carries only the transposase genes whose
products mediate transposition of the elements. The insertion of additional genes, such as
toxin genes, and more often antibiotic resistance genes, creates larger transposons (114).
Composite transposons, such as Tn9, Tn10, and Tn5706, usually have one or more
central antibiotic resistance genes and insertion sequences at the termini. Complex
transposons, such as Tn1721, are commonly characterized by terminal inverted repeats
and occasionally also internal repeats that separate the part carrying resistance gene(s)
from the part carrying transposase genes. Some transposons integrate site specifically,
whereas others can insert at various positions in the chromosomal or plasmid DNA.
Similar to the situation among plasmids, there are also non-conjugative and conjugative
transposons. Conjugative transposons, for instance Tn916, transfer not only among
species within the Gram-positive or Gram-negative bacteria, but also between both
groups. The tetracycline resistance gene, (tetM), located on a conjugative transposon, can
transfer across several genera of bacteria such as Enterococcus spp., Staphylococcus spp.,
Streptococcus

spp.,

Actinomyces

spp.,

Bifidobacterium

spp.,

Clostridia

spp.,
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Campylobacter spp., Fusarium nucleatum, Gardenella vaginalis, Haemophilus spp.,
Neisseria spp., and Veillonella spp (184).
3. Gene Cassettes/ Integrons
Gene cassettes represent small mobile elements of less than 2 kb and were
previously detected only in Gram-negative bacteria (174), but recently have been found
in both Gram-negative and Gram-positive bacteria. They commonly consist of only a
specific recombination site and a single gene, which most often is an antibiotic resistance
gene (45). Gene cassettes do not have replication systems or transposition systems, but
move by site-specific recombination. Gene cassettes can occur as a free circular DNA
molecule, but they are usually found integrated into an integron (45). In recent years
many different and diverse genes responsible for antibiotic resistance have been found in
integrons.
4. Mobile Genomic Islands
Since the 1990s, several mobile genomic islands carrying antibiotic resistance
genes have been reported. These genomic islands integrate site-specifically into the
chromosome. The most well-studied is the Salmonella genomic island 1 (SGI1). This 43kb SGI1 was first identified in epidemic multidrug-resistant strains of S. enterica serovar
Typhimurium DT104. Several studies have shown a high prevalence of SGI1 in S.
Typhimurium DT104. SGI1 has also been identified in other S. enterica serovars, such as
Agona, Albany, Derby, Newport, Meleagridis, and Paratyphi B (28, 67, 144, 220).
Recently, SGI1 has been identified as an integrative mobilizable element. The 13-kb
antibiotic resistance gene cluster within SGI1 consists of a complex integron related to
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the In4 group of integrons. In most known cases, it mediates resistance to a pentadrug
pattern (ACSSuT), including ampicillin (blaPSE-1), chloramphenicol and florfenicol
(floR), streptomycin and spectinomycin (aadA2), sulfonamide (sul1), and tetracycline
(tetG). However, variant clusters have been identified containing additional or other
resistance genes, such as dfrA1 and dfrA10, conferring resistance to trimethoprim; aadA7,
conferring resistance to streptomycin, and aac(3)-ID, conferring resistance to gentamicin
(63, 144, 221).
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III. INTEGRONS AND GENE CASSETTES
Plasmids and transposons are genetic elements that have been found to carry
antibiotic resistance genes. However, numerous studies have shown that many antibiotic
resistance genes found on plasmids and transposons in Gram-negative bacteria are
located at a unique site within the conserved DNA sequence, leading to the discovery of a
new genetic element called an integron.

Integrons are natural genetic engineering

systems that capture and incorporate open reading frames and convert them into
functional genes (1). Aside from antibiotic resistance genes, integrons have been
implicated in the acquisition of virulence determinants by V. cholerae (138) and E. coli
(198).

Classification of Integrons
Integrons are believed to play a major role in the rapid dissemination of multi-drug
resistance (MDR) among bacteria (158). Two major groups of integrons exist. Superintegrons (SI) are chromosomally located and may contain hundreds of gene cassettes
encoding for a variety of functions, and there is a high degree of identity (> 80%)
observed between the attC sites of these cassettes (137, 181). Resistance integrons (RI)
typically carry gene cassettes encoding resistance to antibiotics and disinfectants and are
currently divided into three classes, based on variations in sequence of primary elements,
gene cassettes, and associations with transposons (4, 12, 44, 79, 80, 173, 192). RI can
occur on bacterial chromosomes, transposons, or plasmids. The most common and widely
distributed of RI are class 1 integrons (33, 79, 164, 217). Table 5 provides examples of
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Table 5. Bacteria found to carry integrons.1

Integrons
Resistance integrons

Bacteria
Class 1

Class 2
Class 3
Super integrons

1

Acinetobacter,
Aeromonas,
Alcaligenes,
Burkholderia,
Campylobacter,
Citrobacter,
Enterobacter,
Escherichia,
Klebsiella,
Pseudomonas, Salmonella, Serratia, Shigella,
Vibrio,
Corynebacterium
glutamicum,
and
Mycobacterium fortuitum
Acinetobacter, Shigella, and Salmonella
Pseudomonas aeruginosa, Serratia marcescens,
Alcaligenes xylosoxidans, Pseudomonas putida, and
Krebsiella pneumoniae
Geobacter sulfurreducens, Listonella pelagia,
Nitrosomonas eurapaea, Pseudomonas alcaligenes,
Pseudomonas mendocina, Pseudomonas stutzeri,
Shewanella oneidensis, Shewanella putrefaciens,
Treponema denticola, Vibrio anguillarum, Vibrio
cholerae, Vibrio fischerii, Vibrio metschnikovii,
Vibrio mimicus, Vibrio parahaemolyticus, and
Xanthomonas campestris

Adapted from Fluit and Schmitz (80).
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bacteria that have been reported to carry integrons. Class 1 integrons are widespread and
have been found on all continents (65, 109, 112, 124, 193). Class 1 integrons possess two
conserved segments separated by a variable region that often includes antibiotic
resistance genes. The construct of class 1 integrons includes a conserved intI (integrase)
gene and a complimentary strand containing a common promoter region that is directed
toward the site of integration (127, 159). Site-specific recombination events occur within
integrons enabling promotorless cassettes encoding for a wide range of antibiotic
resistance genes to be inserted downstream of the integron promoter region, thereby
providing for simultaneous resistance to multiple antibiotics (80). Integrons can be
exchanged indiscriminately between similar bacteria as well as among bacteria of
different taxa (110, 236), thus causing concern for wide dissemination
of these genetic resistance elements.

The Structure of Integrons
Class 1 integrons consist of two conserved segments, 5’ and 3’ conserved
sequences, separated by a variable region, which includes one or more genes (Figure 4).
The most common genes inserted into variable regions as cassettes are antibiotic
resistance genes. (43, 127). Gene cassettes are not necessarily part of integrons, but once
incorporated, they become part of that integron (79). Integrons can carry several different
gene cassettes and therefore play an important role in the dissemination of multiple
antibiotic resistance genes.
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1. 5’Conserved Sequences
The 5’ conserved sequence of integrons consists of three elements necessary for
the capture of gene cassettes; a gene encoding a site specific recombinase integrase
enzyme (intI); an attachment site where horizontally acquired sequences are integrated
(attI); and a promoter that drives expression of the incorporated sequence (P) (89, 137,
158, 182).
Integrase
The IntI gene encoding for the integrase enzyme belongs to the tyrosine-recombinase
family, which is the same as a well known λ-integrase (72, 156). The integron integrase
is similar in length; however, it shares only 40-60% homology of amino acid identity.
The IntI2 and IntI3 are 46% and 59% identical to IntI1, respectively (46). It is important
to note that despite the differences in the integrase, gene cassettes are thought to be
acquired by all integron classes, as identical genes cassette have been found in different
classes of integron (12, 174, 203).
Integron Attachment Sites
Integrase enzymes catalyze the excision and integration of antibiotic resistance
genes in integrons by a site-specific recombination system. These reactions occur by the
integrase interacting with the two different recombination sites, the integron attachment
site (attI) in the 5' conserved segment of the integron and the cassette attachment site
(attC) or 59 base element (59-be) of the gene cassettes (45, 143, 163). The integrase
cleaves double stranded DNA in both attI and attC sites between G and the first T within
a 7-bp sequence (GTTRRRY, where R is a purine and Y is a pyrimidine), known as a
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Figure 4. Typical genetic organization of class 1 integrons.
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core site (201) creating a cross-over recombination point (91, 163). A diagram of the
gene cassette capture and expression mechanism of class 1 integrons is show in Figure 5.
Promoters
Most antibiotic resistance gene cassettes are inserted into integrons as promoterless
elements, therefore the expression of the genes located in the cassettes depend on the
promoter located downstream of attI site. In class 1 integrons the 5’-CS contains 2
potential promoters, P1 (also called PANT) and P2. These promoters vary in strength to up
to 20 times with P1 generally being a strong promoter and P2 being a weaker Promoter,
or frequently, inactive because only 14 nucleotides are present between the -35 and -10
boxes of this promoter, instead of the optimal 17 nucleotides. At least five different P1
and two different P2 sequences have been described, which may occur in varying
combinations (42, 94, 126, 167, 201).
2. Gene Cassettes
Gene cassettes are discrete genetic elements that may exist as free, circular, nonreplicating DNA molecules when moving from one genetic site to another (43); but they
are normally found as linear sequences that constitute part of a larger DNA molecule,
such as a plasmid or bacterial chromosome. Gene cassettes normally contain only a single
gene and an additional short sequence, attC, that functions as a specific recombination
site (90). Accordingly, the cassettes are small, normally of the order of 500–1000 bp.
Most gene cassettes lack the promoter in front of the coding sequence, therefore
the expression of the genes located in the cassettes depends on the promoter of the
integron (79). The number of identifie d resistance gene cassettes associated with RI
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Figure 5. Schematic representation of gene cassette capture and expression
mechanism by class 1 integrons. Adapted from Harbottle et al. (96), and Rowe-Magnus
and Mazel (182).
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increased dramatically from 40 different genes cassettes in 1998 (92) to 60 in 1999 (79),
and over 80 have been reported to be associated with class 1 integrons in 2006 (137).
Incorporation of gene cassettes into integrons occurs by IntI-mediated site-specific
recombination between a 59-base element site in the cassette and an integron attachment
site (attI) site in the integron (41). The following are details of attC and varying types of
gene cassettes.
Cassette Attachment Site
The attC sites present at the 3’-end of a cassette are a diverse family of nucleotide
sequences that function as recognition sites for the site-specific integrase. They vary in
length from 57 bp to 141 bp; however, they share a region of about 25 bp at each end
which conforms to consensus sequences (43, 90, 202). The consensus sequences are
imperfect inverted repeats of one another, which begin with an inverted core site
(RYYYAAC) separated by spacer of 7 or 8 bp and end with a core site (GTTRRRY)
(202).

Although they have similar DNA sequences at their extremities, each gene

cassette has its own version of attC (90, 202). However attC can be recognized by the
same integrase, as the same gene cassettes have been found located within different
classes of integrons, indicating that the pool of cassettes is shared.
Type of Gene Cassettes
More than 70 gene cassettes with nucleotide sequences that differ by more than
5% have been found associated with class 1 integrons. Among them they confer
resistance to all known β-lactams, all aminoglycosides, chloramphenicol, trimethoprim,
streptothricin, rifampin, erythromycin, fosfomycin, and lincomycin and are also found to

60

carry genes coding for resistance to antiseptics of the quaternary-ammonium-compound
family (80, 137, 183). Following are descriptions of four major resistance gene cassettes.
1. β-Lactams Resistance Gene Cassettes: Recently twenty-five gene cassettes
conferring resistance to β-lactam antibiotics were characterized (80). Resistance to this
group of antibiotics is not only caused by classical β-lactamase but also by extended
spectrum β-lactamases. Carbapenamases, β-lactamases that have zinc at their active
centers instead of serine, as in most β-lactamases, and have the ability to hydrolyze most
beta-lactams including carbapenems (79), have also been described. Among four classes
of carbapenamases, the metallo-beta-lactamases (mostly of the IMP and the VIM series)
are the most clinically-significant and have been reported worldwide (154, 160, 168,
205).
2. Aminoglycoside Resistance Gene Cassettes: A large number of gene
cassettes confer resistance to aminoglycosides. Twenty-six aminoglycoside resistance
gene cassettes have been reported (79, 80). Aminoglycoside adenyltransferase (aad)
conferring resistance to streptomycin and spectinomycin is the most common gene
cassette found in this group. The second common aminoglycoside resistance gene
cassette is aminoglycoside acetyltransferase (aac). Its products confer resistance to
neomycin, gentamicin, tobramycin, and kanamycin (79).
3. Trimethoprim Resistance Gene Cassettes:

Two main families of

dihydrofolate reductase (dfr) comprise gene cassettes that confer resistance to the drug
trimethoprim. They are grouped into two main families, A and B. At least 20 different
dfrA sequences and 5 dfrb have been reported so far. Trimethoprim resistance in
clinically significant Gram-negative bacteria is usually caused by horizontally
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transferable resistance genes (dfr genes) coding for alternative resistant dihydrofolate
reductases (104, 172).
4. Chloramphenicol Resistance Gene cassettes: This gene cassette’s product
confers resistance to chloramphenicol either via acetylation or efflux pump. Two main
families of gene cassettes are responsible for chloramphenicol resistance, cat and cml.
The former families are involved in drug modification, whereas the latter families
produce products that promote activity of a chloramphenicol efflux pump (79, 183).
3. 3’Conserved Sequence
Most class 1 integrons have a 3’ conserved sequence (3’CS). The 3’CS carries
qacEΔ1 gene, a semi functional derivative of the quaternary ammonium compounds
resistance gene, qacE, the sulfonamide resistance gene (sul1), and an open reading frame
of unknown function called ORF5. Similar 3’CS are not found in other classes of
integrons. (91, 93, 183)
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IV. THE BACTERIA
The population of resistant microorganisms in a host organ depends upon the
ability of the system to harbour a large commensal flora (57). The digestive tract is the
largest reservoir of commensal bacteria within the host and has been found to be the
largest reservoir of resistance genes (216). This has been ascribed to the fact that the huge
intestinal microflora forms an ideal environment for horizontal gene transfer (34). Three
types of bacteria were included in this study, Escherichia coli, Salmonella spp. and
Proteus mirabilis, and thus a discussion of those organisms follows.

Escherichia coli
Although normally commensal, some strains of E. coli are associated with
infections in humans and animals. In swine, pathogenic E. coli can cause enteric
colibacillosis, edema disease or mastitis metritis agalactia syndrome (MMA). Enteric
colibacillosis, or piglet scours, causes diarrhea and dehydration in first few days of life
and in piglets 1-2 weeks of age. This diarrhea is responsible for significant economic
losses due to mortality, morbidity, decreased growth rate, and cost of medication (62, 73,
88). Edema disease, or E. coli enterotoxaemia, affects growing pigs several weeks after
weaning. It is often rapidly fatal (73). MMA occurs in sows just after farrowing and
results in a lack of milk which causes high piglet mortality. In chickens, E. coli may
cause infections of the respiratory tract and soft tissues, resulting in colibacillosis, air
sacculitis, and cellulitis. E. coli can also cause yolk sac infections, which is a common
cause of chick mortality in the first week of life.
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Salmonella spp.
Salmonella is a genus of rod-shaped Gram-negative enteric bacteria. There are
currently 2,463 known Salmonella serotypes (169). This genus of bacteria can be divided
into 3 groups according to clinical syndrome in humans: typhoid fever, bacteremia, and
enterocolitis (187). Among those syndromes only bacteremia and enterocolitis, caused by
non typhoidal S. enterica serotypes, are associated with animal reservoirs and human
disease outbreaks caused by this bacterium, commonly resulting from animal to human
transmission. In contrast, typhoid fever, caused by typhoidal S. enterica serotypes, do not
have animal reservoirs and are maintained in human populations by person to person
transmission (146). Salmonellosis is a major cause of bacterial enteric illness in both
humans and animals. On the global scale, it has been estimated that each year about 1.3
billion cases of gastroenteritis due to nontyphoidal salmonellosis occur, resulting in 3
million deaths (161). Among humans in the United States, an estimated 1.4 million cases
of salmonellosis occur annually (141). Furthermore, Salmonella-induced enterocolitis is
the single most common cause of death from foodborne illness associated with viruses,
parasites or bacteria in the United State (141). Transmission of Salmonella in food
animals typically occurs through fecal-oral or aerogenous transmission. Rodents, insects,
cats, birds, humans, contaminated feed, and transportation vehicles can act as vectors for
dissemination of Salmonella. Although animal to human transmission may occur through
direct contact, the most important source of human infection is contaminated food
products of animal origin (100). In the United States, chicken, beef, turkey and eggs are
the most common food vehicles for transfer of Salmonella to humans. Salmonella
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contamination of food and food products may occur either because animals are infected
or because fecal contamination occurs during food processing.

Proteus mirabilis
Proteus mirabilis is a rod-shaped Gram-negative, facultative anaerobic bacterium
belonging to family Enterobacteriaceae. This bacterium is part of the normal gut flora of
a healthy individual, but is also an opportunistic pathogen. P. mirabilis is an important
opportunistic uropathogen that is frequently isolated from patients with complications
from urinary tract infections (199, 237). Recently, several research groups have reported
the presence of mobile genetic elements involved in antibiotic resistance dissemination in
P. mirabilis. For example, clinical P. mirabilis isolates harboring Salmonella genomic
island 1 containing the multiple antibiotic resistance regions have been reported in Japan
(3). Using PCR targeting conserved sequences of integrons, Tsakris et al. (213) noted that
the blaVIM-1 allele in P. mirabilis strains that were phenotypically metallo-ß-lactamase
(MBL)-positive, was located in a common integron structure. Class 1 integrons were also
detected as common carriers of antibiotic resistance genes, such as aadA1, aadB, and
aadA2, in multidrug-resistant isolates of P. mirabilis collected from retail meat in
Oklahoma, Japan (116).
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CHAPTER 3: PREVALENCE OF CLASS 1 INTEGRONS AND
ANTIBIOTIC RESISTANCE PATTERNS IN BACTERIA OF
BROILER CHICKENS IN THE US AND THAILAND
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ABSTRACT
The objective of this study was to investigate the prevalence of class1 integrons
and antimicrobial resistance patterns in E. coli, P. mirabilis, and Salmonella isolates of
commercial chickens from the US and Thailand. Class 1 integrons, as indicated by the
presence of intI1, were detected in 1,732 isolates (45.4%) of the total 3,824 isolates.
Simultaneous presence of all three conserved genes (intI1, qacEΔ1, and sul1) was found
in 1,044 (27.3%) isolates. The prevalence of class 1 integrons in E. coli and Salmonella
spp. isolates was found to differ with isolate origin (P<0.001). In both types of bacteria,
class 1 integrons were more prevalent in isolates from Thailand compared with the US
(70.3% and 44.6% of E. coli isolates and 48.1% and 0.5% of Salmonella spp. isolates
from Thailand and the US, respectively). Among P. mirabilis, 29.9% of isolates from the
US carried integrons; however, this prevalence was not different (P=0.81) from that of
isolates from Thailand (38.2%). Most isolates were found to be multi-antibiotic resistant.
A high proportion of isolates demonstrated resistance to tetracycline (80.2%),
sulfonamides (67.7%), cephalothin (62.5%), and ampicillin (57.8%), whereas no isolates
were resistant to amikacin. Integron-positive isolates were more likely to be resistant to
sulfamethoxazole than integron-negative isolates. Thailand isolates had a greater
occurence

of

resistance

(P<0.01)

to

chloramphenicol,

nalidixic

acid,

and

trimethoprim/sulfamethoxazole than isolates from the US. Whereas, both E. coli and
Salmonella isolates from the US demonstrated a greater prevalence of resistance (P<0.01)
to amoxicillin/clavulanic acid, cefoxitin, and ceftiofur than those from Thailand.
Salmonella and P. mirabilis isolates from the US were also more frequently resistant
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(P<0.01) to cephalothin than isolates from Thailand. Among 85 antibiotic resistance
patterns found in antibiotic susceptibility tests, 11 patterns were found in both integronpositive and integron-negative isolates, and only one pattern, resistance to tetracycline,
was found among isolates from both countries. These results indicate that class 1
integrons are common in commensal and foodborne bacteria in chickens, and that some,
but not all, antibiotic resistances in those isolates were found in the presence of class 1
integrons.
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I. INTRODUCTION
Food animals are often exposed to antimicrobials to treat and prevent infectious
diseases or to promote growth (37). Antimicrobial usage in food animals provides
selection pressure that favors an increase of antimicrobial resistance in bacteria (23, 29,
32, 34). Antimicrobial resistance has emerged not only in commensal bacteria and
bacterial pathogens of animals but also in zoonotic enteropathogens (37). Resistant
bacteria from animals can infect humans by direct contact and also via consumption of
food products of animal origin (60, 63). These resistant bacteria can colonize humans
and/or transfer their resistance genes to other bacteria of humans, which can result in
treatment failure as a consequence of that antimicrobial resistance (61).
Integrons are genetic elements that mediate integration of antibiotic resistance
genes through site specific recombination and convert them into functional genes (14, 20,
27, 35, 49). More than 70 different genes imparting resistance to most classes of
antibiotics have been found as gene cassettes in the central region of different integrons
from diverse bacteria (51). Moreover, these genetic elements can incorporate several
resistance genes, allowing them to transfer as a single gene. As many as seven gene
cassettes have been found within an integron (58). Integrons are often found to be carried
on mobile elements such as plasmids and transposons; therefore integrons are believed to
play a major role in the rapid dissemination of multi-drug resistance among bacteria (43).
Four different classes of integrons have been identified based on variations in sequence
of primary elements, gene cassettes, and associations with transposons (3, 5, 15, 19, 20,
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47, 52). Class 1 integrons are the most common and widely distributed type (10, 19, 45,
55).
The U.S. and Thailand, while occupying very diverse geographic regions, share
many commonalities in livestock production practices. Broiler chicken production tends
to be intensive, with closed confinement, high biosecurity and similar high production
genetic lines. Feed-based antibiotics are commonly used in both countries, although some
differences occur in drugs of choice and/or availability. A comparison of class 1 integron
prevalence and antibiotic resistance gene patterns of Escherichia coli, Salmonella spp.,
and Proteus mirabilis between these two countries may provide information regarding
global implications of agricultural use of antibiotics with regard to antibiotic resistance.
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II. MATERIALS AND METHODS
Bacterial Isolates
A total of 2,137 E. coli, P. mirabilis and Salmonella spp. isolates were collected
via fecal swab from 1,270 broiler chickens from 7 farms at abattoirs in the US, and 1,050
isolates were collected from 427 broiler chickens from 2 farms in Thailand. All bacterial
collections from Thailand took place in southern Thailand during the period of May 2003
to August 2004, whereas bacterial collections from the US took place in Tennessee
during the period of January to May 2005. All isolates were recovered from fecal swabs
by standard microbiological procedures. The primary isolation method for E. coli has
been described previously (36). For Salmonella and P. mirabilis isolation, fecal swabs
were first enriched in selective tetrathionate broth (Difco, Sparks, MD) and incubated at
41.5+1ºC for 18-24 h. Enriched broth cultures were then plated on Xylose Lysine
Tergitol 4 agar (XLT4; Difco) for selective culture. Plates were incubated at 37+1ºC and
examined after 18-24 h. Presumptive Salmonella and P. mirabilis colonies were
subcultured and then plated again, and identity was confirmed with API 20E strips
according to the manufacture’s specification (bioMérieux Vitek, Inc., Hazelwood, MO).
Up to 6 colonies of each bacterial type were selected for analysis. Bacterial cultures were
maintained at -80°C in 10% glycerol until analysis.

Multiplex PCR (MP-PCR)
Integron harboring isolates were detected using a MP-PCR targeting three
conserved sequences of class 1 integrons, intI1, qacEΔ1, and sul1 (18). Primer pairs were
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manufactured by Operon, Inc. (Alameda, CA) (Table 1). Total DNA was prepared by
boiling overnight cultures in 2YT broth (Difco) in an equal volume of 0.2% (wt/vol)
Triton X-100 (Mallinckrodt, Paris, KY) for 5 min (30). Boiled cultures were cooled on
ice for 5 min and used immediately for PCR. PCR reagents, excluding template DNA,
were combined in a master mix prior to aliquoting. The final reaction volumes for each
aliquot included: 1) 1 μL of each primer pair (50 pmol (each primer) μL-1); 2) 1 μL of
Taq DNA polymerase (0.5U μL–1; Promega, Madison, WI); 3) 10 μL reaction buffer
(12.5mM MgCl2, pH 8.5; Invitrogen, Carlsbad, CA); 4) 5 μL dNTPs solution (2.5mM of
each dNTP, pH 8.0; Invitrogen); and 5) 32 μL sterile H2O. Sample DNA (1 μL) was then
added to each aliquot. Reactions were conducted in a Mastercyler Gradient thermocycler
(Eppendorf, Westbury, NJ) with the following conditions: 1) 1 cycle of 94°C for 4 min;
2) 10 "touchdown" cycles of 94°C for 1 min, 65°C for 30s (decreasing 1°C/cycle), 70°C
for 2 min; 3) 24 cycles of 94°C for 1 min, 55°C for 30s, 70°C for 2 min; and 4) 1 final
cycle of 70°C for 5 min. Salmonella Typhimurium DT104 known to contain two class 1
integrons (23) was used as a positive control. A blank containing only PCR reagents and
Triton X-100 was used as a negative control. Reaction products were separated by
conventional electrophoresis in 1.5 % agarose and stained with ethidium bromide for
visualization (Figure 1). Prevalence of class 1 integrons was based on the presence of the
IntI1 gene.
The integron prevalence in each bacterial species was compared between
Thailand and the US using the freq procedure of SAS (SAS 8.2, SAS Institute Inc, Cary,
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Table 1. Primer pairs used in MP-PCR.
Target
int1
sul1
qacEΔ1

Sequence (5’ to 3’)
(F) GGTTCGAATGTCGTAACCGC
(R) ACGCCCTTGAGCGGAAGTATC
(F) ATCAGACGTCGTGGATGTCG
(R) CGAAGAACCGCACAATCTCG
(F) GAGGGCTTTACTAAGCTTGC
(R) ATACCTACAAAGCCCCACGC

PCR Product
(bp)
248
346
200
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1
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1
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5

6

7

6

7

8

9

10

8

9

10

sul1 (346bp)
IntI1 (248bp)

qacEΔ1 (200bp)

Figure 1. Multiplex PCR detecting class 1 integrons gene sequence.
Lane 1 and 10; 100 bp DNA ladders; Lane 2-7 wild type isolates; lane 8; negative
control; and lane 9; Salmonella enterica Typhimurium DT104 (positive control)
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NC) Comparisons were made using the Fisher's two-sided exact tests. Differences were
considered significant at P < 0.05.

Antibiotic Susceptibility Testing
Antibiotic MICs were determined for subsets of each bacterial type using the
National Antimicrobial Resistance Monitoring System (NARMS) microdilution sensititre
plates, CMV7CNCD, (Sentititre, Trek Diagnostic System Inc., Cleveland, Ohio)
according to Clinical and Laboratory Standards Institute (CLSI), (formerly National
Committee on Clinical Laboratory Standards, NCCLS) broth microdilution guidelines.
E.coli ATCC 25922 was used as a reference strain. The isolates were tested for resistance
to 16 antibacterials or antibacterial combinations that included: amoxicillin/clavulanic
acid (Aug), ampicillin (Amp), ciprofloxacin (Cip), cefoxitin (Fox), ceftiofur (Tio),
ceftriaxone (Axo), cephalothin (Cpl), chloramphenicol (Chl), amikacin (Ami),
gentamicin (Gen),

kanamycin (Kan), nalidixic acid (Nal), streptomycin (Str),

sulfamethoxazole (Sul), tetracycline (Tet), and trimethoprim/sulfamethoxazole (Sxt).
The CMV7CNCD plate layout is shown in Figure 2. Results were interpreted using CLSI
guidelines for broth microdilution methods for veterinary E. coli (Table 2). In the
phenotypic analysis, isolates with intermediate MICs were not considered as resistant.
The frequency of antibiotic resistance in integron-positive isolates was compared
to that of integron-negative isolates and frequency of antibiotic resistance in isolates from
Thailand was compared to the US using the Analysis and Statcalc programs of the Epi
InfoTM version 3.4.1 software package from the Centers for Disease Control and
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Prevention (11). Comparisons were made using Fisher's two-sided exact tests.
Differences were considered significant at P<0.05.
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8

9
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16
Fox
8
Fox
4
Fox
2
Fox
1
Fox
0.5
Ami
4
Ami
2

Ami
1
Ami
0.5
Chl
32
Chl
16
Chl
8
Chl
4
Chl
2
Tet
32

Tet
16
Tet
8
Tet
4
Axo
64
Axo
32
Axo
16
Axo
8
Axo
4

Axo
2
Axo
1
Axo
0.5
Axo
0.25
Aug
32/16
Aug
16/8
Aug
8/4
Aug
4/2

Aug
2/1
Aug
1/0.5
Cip
4
Cip
2
Cip
1
Cip
0.5
Cip
0.25
Cip
0.12

Cip
0.06
Cip
0.03
Cip
0.015
Gen
16
Gen
8
Gen
4
Gen
2
Gen
1

Gen
0.5
Gen
0.25
Nal
32
Nal
16
Nal
8
Nal
4
Nal
2
Nal
1

Nal
0.5
Tio
8
Tio
4
Tio
2
Tio
1
Tio
0.5
Tio
0.25
Tio
0.12

Sul
512
Sul
256
Sul
128
Sul
64
Sul
32
Sul
16
Sxt
4/76
Sxt
2/38

Sxt
1/19
Sxt
0.5/9.5
Sxt
0.25/4.75
Sxt
0.12/2.38
Cpl
32
Cpl
16
Cpl
8
Cpl
4

Cpl
2
Kan
64
Kan
32
Kan
16
Kan
8
Amp
32
Amp
16
Amp
8

Amp
4
Amp
2
Amp
1
Str
64
Str
32
Pos
Pos
Pos

Figure 2. Sensititre non-fastidious Gram negative plate (CMV7CNCD) format.
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline;
Pos, growth control wells.
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Table 2. Minimum Inhibitory Concentration (MIC) breakpoint. 1
Drugs
Aminoglycoside
Amikacin (Ami)
Gentamicin (Gen)
Kanamycin (Kan)
Streptomycin (Str)
β-Lactams
Ampicillin (Amp)
Amoxicillin/Clavulanic acid (Aug)
Cephalothin (Cpl)
Cefoxitin (Fox)
Ceftiofur (Tio)
Ceftriaxone (Axo)
Chloramphenicol (Chl)
Quinolone
Ciprofloxacin (Cip)
Nalidixic Acid (Nal)
Sulfonamides
Sulfamethoxazole (Sul)
Trimethoprim/Sulfamethoxazole (Sxt)
Tetracycline (Tet)

Susceptible
(μg/ml)

Intermediate
(μg/ml)

Resistant
(μg/ml)

≤ 16
≤4
≤ 16
≤ 32

32
8
32

≥ 64
≥ 16
≥ 64
≥ 64

≤8
≤ 8/4
≤8
≤8
≤2
≤8
≤8

16
16/8
16
16
4
16,32
16

≤1
≤ 16

2

≤ 256
≤ 2/38
≤4

8

≥ 32
≥ 32/16
≥ 32
≥ 32
≥8
≥ 64
≥ 32
≥4
≥ 32
≥ 512
≥ 4/76
≥ 16

1

MICs determined via microdilution broth methods in accordance with CLSI standards
(12, 13).
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III. RESULTS
Prevalence of Bacterial Isolates
The frequency of E. coli isolates from chickens was high in both countries with
97.4% and 95.8 % of chickens from Thailand and the US, respectively, carrying E. coli.
However, the prevalence of Salmonella spp. and P. mirabilis in chickens was
considerably lower than E. coli. The prevalence of Salmonella was higher in the US, with
that organism being detected in 21.2% of chickens, whereas only 3% of chickens in
Thailand were found to carry Salmonella. A similar prevalence of P. mirabilis was found
in Thailand and the US with 12.2 and 11.8% of chickens from Thailand and the US,
respectively, were found to carry these bacteria. However, the prevalence of both bacteria
varied between farms ranging from 0 to 66% and 0 to 5.2% for Salmonella isolates and
1.3 to 24.3% and 7.0 to 20.6% for P. mirabilis isolates from the US and Thailand,
respectively. Table 3 shows the number of positive samples for each type of bacteria and
their distribution by country and farm.
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Table 3. Prevalence of E. coli, Salmonella, and P. mirabilis of chickens in the US and
Thailand.

Countries

Farm

# of
animals
sampled

# of animals carrying bacteria (%)
E. coli

Salmonella

P. mirabilis

US

US 1
US 2
US 3
US 4
US 5
US 6
US 7
Total

70
150
150
150
150
300
300
1,270

67 (95.7)
145 (96.7)
147 (98.0)
142 (94.5)
139 (92.7)
287 (95.7)
290 (96.7)
1,217(95.8)

8 (11.4)
99 (66.0)
24 (16.0)
27 (18.0)
9 (6.0)
102 (34.0)
0 (0)
269 (21.2)

4 (5.7)
2 (1.3)
12 (8.0)
14 (9.3)
23 (15.3)
22 (7.3)
73 (24.3)
150 (11.8)

Thailand

TH 1
TH 2
Total

267
160
427

267 (100)
149 (93.0)
416 (97.4)

14 (5.2)
0 (0)
14 (3.3)

19 (7.0)
33 (20.6)
52 (12.2)
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Prevalence of Class 1 Integrons
Prevalence of class 1 integrons in E. coli, Salmonella spp., and P. mirabilis in
chickens from the US and Thailand is shown in Table 4. Class 1 integrons, as indicated
by the presence of intI1, were detected in 1,732 isolates (45.4%). Simultaneous presence
of all three conserved genes (intI1, qacEΔ1, and sul1) was found in 1,044 (27.3%) of the
total of 3,824 isolates. The prevalence of class 1 integrons in E. coli and Salmonella spp.
was found to differ with isolate origin (P<0.001). In both types of bacteria, class 1
integrons were more prevalent in isolates from Thailand when compared with the US.
(70.3 and 44.6% for E.coli isolates, 48.1 and 0.5% for Salmonella spp. isolates from
Thailand and the US, respectively). Among P. mirabilis, 29.9% of isolates from US
carried integrons; however this was not different from Thailand (38.2%) (P=0.81). There
were no differences in prevalence of class 1 integrons across farms among Salmonella
spp. (P=0.99). In contrast, the prevalence of integrons across farms in both E. coli and P.
mirabilis isolates differed (P<0.001) (data not shown)
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Table 4. Prevalence of integrons and integron component genes in bacteria of chickens
from the US and Thailand. 1
E. coli

No. of isolates
No.(%) carrying
- IntI1 (I)
- All 3 conserved
genes (I, Q, S)

P. mirabilis
The US

Thailand

Salmonella

The US

Thailand

The US

Thailand

1161

1341

279

334

576

133

518
(44.6)b
502
(43.2)a

942
(70.3)a
307
(22.9)b

83
(29.9)a
83
(29.9)a

127
(38.2)a
96
(28.8)a

3
(0.5)b
3
(0.5)b

64
(48.1)a
53
(39.9)a

1

Results are reported as numbers and percentage of bacteria carrying integrons and genes
associated with integrons, as determined by multiplex PCR. I, intI1; Q, qacEΔ1; S, sul1.
a,b
Values within the same bacteria and row not sharing like superscripts differ (P<0.05).
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Antibiotic Susceptibility
E. coli isolates
A comparison of antibiotic resistance patterns between integron-positive and
integron-negative E. coli isolates is shown in Figure 3. The highest percentage of
resistance in integron-positive E. coli was found to tetracycline (100%), followed by
sulfamethoxazone (97.8%), cephalothin (75.6%), streptomycin (71.1%) and gentamicin
(62.2%); whereas 100, 82.2, 68.9, 55.6, and 51.1 % of integron-negative isolates showed
resistance to tetracycline, cephalothin, ampicillin and sulfamethoxazone, respectively. All
integron-negative isolates were susceptible to chloramphenicol and amikacin, whereas all
integron-positive isolates were only susceptible to amikacin. Integron-negative isolates
demonstrated a low percentage of resistance (2.2–20%) to ceftriaxone, gentamicin,
kanamycin, ciprofloxacin, trimetroprim/sulfamethoxazole and nalidixic acid. Among
integron-positive isolates, 2.2 to 28% of isolates were resistant to ceftriaxone,
chloramphenicol, ciprofloxacin, kanamycin and nalidixic acid. Resistance to gentamicin,
kanamycin, chloramphenicol, and sulfamethoxazole was more common in integron–
positive isolates (P<0.05).
Compared to Thailand, US isolates showed a higher percentage of resistance to
tetracycline,

cephalothin,

streptomycin,

sulfamethoxazole,

ampicillin,

amoxicillin/clavulanic acid, ceftiofur and cefoxitin (100, 81.4, 77.1, 70, 61.4, 58.6, 57.1
and 54.3%, respectively). All US isolates were susceptible to amikacin, chloramphenicol,
and ciprofloxacin and showed a high level of susceptibility (85.7-97.3%) to kanamycin,
trimethoprim/sulfamethoxazole, nalidixic acid, and ceftriaxone.
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Figure 3. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative E. coli from chickens.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05)

106

All Thailand isolates were resistant to tetracycline and showed a high resistance to
nalidixic

acid,

sulfamethoxazole,

sulfamethoxazole,
cephalothin,

cephalothin,

ciprofoxacin,

ciprofloxacin

nalidixic

trimethoprim/sulfamethoxazone

acid,
and

ampicillin (95, 90, 70, 65, 65 and 60%, respectively). All E. coli isolates from Thailand
were susceptible to amikacin, gentamicin, cefoxitin, and ceftriaxone. Only 5, 10, 25 and
35 % of E. coli isolates from Thailand were resistant to ceftiofur, amoxicillin/clavulanic
acid, chloramphenicol, and kanamycin.

Resistance to gentamicin, streptomycin,

amoxicillin/clavulanic acid, cefoxitin and cetriofur was more common in US isolates
(P<0.05); whereas isolates from Thailand showed a higher percentage of resistance to
kanamycin,

chloramphenicol,

ciprofloxacin,

trimethoprim/sulfamethoxazole,

and

nalidixic acid than isolates from the US (P<0.0001) (Figure 4).
Overall, all E. coli isolates from chickens were resistant to at least one antibiotic.
Integron-positive and -negative isolates were resistant to 2 to 10 and 1 to 10
antimicrobials, respectively. The highest proportion of integron–positive isolates was
resistant to 9 antimicrobials, whereas the highest proportion of integron-negative isolates
was resistant to 6 antimicrobials. E. coli isolates from the US and Thailand were resistant
to 2 to 10 and 1 to 9 antimicrobials, respectively. Whereas 90% of E. coli isolates from
Thailand were resistant to more than 5 antimicrobials, only 62% of isolates from the US
showed resistance to that number of antimicrobials (Figure 5).
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Figure 4. Frequency of resistance to 16 antimicrobials in E. coli of chickens from the
US and Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05)
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Figure 5. Multiple antimicrobial resistance of E. coli from chickens.
A. Integron-positive and integron-negative isolates.
B. Isolates from the US and Thailand.
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A total of 47 patterns were observed among 90 E. coli isolates. The most frequent
pattern was resistance to 9 antimicrobials, Aug-Amp-Fox-Tio-Cpl-Gen-Str-Sul-Tet,
which was found in 11.1% of isolates. Seven isolates (7.8%) exhibited resistance to the
highest number of antimicrobials (10) with those being Aug-Amp-Fox-Tio-Cpl-KanGen-Str-Sul-Tet and Aug-Amp-Fox-Tio-Cpl-Gen-Str-Sul-Tet-Sxt. Among the 47
patterns, eight patterns were found in both integron-positive and integron-negative
isolates. However, no common pattern was found among isolates from Thailand and the
US (Table 5).

110

Table 5. Antibiograms of E. coli isolates of chickens from the US and Thailand.
No. of isolate(s)
Pattern
No.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Antibiogram1

Aug-Amp-Fox-Tio-Axo-Cpl-StrSul-Tet
Aug-Amp-Fox-Tio-Axo-CplSul-Tet-Sxt
Aug-Amp-Fox-Tio-Cpl-KanGen-Str-Sul-Tet 2
Aug-Amp-Fox-Tio-Cpl-Kan-StrSul-Tet
Aug-Amp-Fox-Tio-Cpl-GenNal-Sul-Tet
Aug-Amp-Fox-Tio-Cpl-Gen-StrSul-Tet-Sxt
Aug-Amp-Fox-Tio-Cpl-Gen-StrSul-Tet 2
Aug-Amp-Fox-Tio-Cpl-Str-SulTet-Sxt 2
Aug-Amp-Fox-Tio-Cpl-Str-SulTet
Aug-Amp-Fox-Tio-Cpl-Str-Tet
Aug-Amp-Fox-Tio-Cpl-Sul-TetSxt
Aug-Amp-Fox-Tio-Cpl-Sul-Tet2
Aug-Amp-Fox-Tio-Cpl-Tet
Aug-Amp-Fox-Cpl-Str-Sul-Tet
Aug-Amp-Tio-Cpl-Cip-Nal-SulTet
Aug-Amp-Tio-Cpl-Gen-Str-SulTet
Aug-Amp-Tio-Cpl-Str-Sul-Tet
Aug-Amp-Tio-Cpl-Str-Tet
Aug-Amp-Cpl-Cip-Nal-Sul-TetSxt
Aug-Amp-Cpl-Str-Tet
Amp-Fox-Tio-Cpl-Tet
Amp-Cpl-Chl-Cip-Kan-Nal-SulTet-Sxt

Integron

Location

Total

+

-

US

Thailand

(n=45)

(n=45)

(n=70)

(n=20)

(n=90)

0

1

1

0

1

1

0

1

0

1

4

1

5

0

5

0

1

1

0

1

1

0

1

0

1

2

0

2

0

2

9

1

10

0

10

1

1

2

0

2

0

3

3

0

3

0
0

2
1

2
1

0
0

2
1

3
0
0
0

1
3
1
1

4
3
1
0

0
0
0
1

4
3
1
1

0

1

1

0

1

0
0
0

1
1
1

1
1
0

0
0
1

1
1
1

0
0
2

1
1
0

1
1
0

0
0
2

1
1
2
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Table 5. (continued) Antibiograms of E. coli isolates of chickens from the US and
Thailand.
No. of isolate(s)
Pattern
No.
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47

Antibiogram1

Amp-Cpl-Cip-Nal-Sul-Tet-Sxt 2
Amp-Cpl-Nal-Sul-Tet-Sxt
Amp-Chl-Cip-Kan-Nal-Str-SulTet
Amp-Chl-Cip-Nal-Str-Sul-TetSxt
Amp-Cip-Nal-Sul-Tet-Sxt
Amp-Gen-Str-Sul-Tet
Amp-Nal-Tet
Cpl-Chl-Cip-Kan-Nal-Str-SulTet-Sxt
Cpl-Cip-Nal-Str-Sul-Tet
Cpl-Kan-Gen-Nal-Str-Sul-Tet
Cpl-Kan-Gen-Str-Sul-Tet 2
Cpl-Kan-Nal-Str-Sul-Tet-Sxt
Cpl-Kan-Nal-Str-Sul-Tet
Cpl-Gen-Str-Sul-Tet-Sxt
Cpl-Gen-Str-Sul-Tet 2
Cpl-Gen-Sul-Tet
Cpl-Na-Str-Sul-Tet-Sxt
Cpl-Str-Tet
Cpl-Tet 2
Cip-Kan-Nal-Str-Sul-Tet
Kan-Str-Sul-Tet-Sxt
Gen-Nal-Str-Sul-Tet
Gen-Str-Sul-Tet
Str-Tet
Tet

Integron

Location

Total

+

-

US

Thailand

(n=45)

(n=45)

(n=70)

(n=20)

(n=90)

2
1
1

1
0
0

0
0
0

3
1
1

3
1
1

1

0

0

1

1

1
1
0
1

0
0
1
0

0
1
0
0

1
0
1
1

1
1
1
1

0
1
1
0
1
1
1
1
0
0
1
0
1
1
5
0
0

1
0
1
1
0
0
1
0
2
4
3
1
0
0
0
5
1

0
1
2
0
0
1
2
1
0
4
4
0
1
1
5
5
0

1
0
0
1
1
0
0
0
2
0
0
1
0
0
0
0
1

1
1
2
1
1
1
2
1
2
4
4
1
1
1
5
5
1

1

Aug, Amoxicillin/Clavulanic Acid; Amp, Ampicillin; Fox, Cefoxitin; Tio, Ceftiofur;
Axo, Ceftriaxone; Cpl, Cephalothin; Chl, Chloramphenicol; Cip, Ciprofloxacin; Gen,
Gentamicin; Kan, Kanamycin; Nal, Nalidixic Acid; Str, Streptomycin; Sul,
Sulfamethoxazole; Tet, Tetracycline; Sxt, Trimethoprim/Sulfamethoxazole.
2
Resistance pattern found in both integron-positive and integron-negative isolates.
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Salmonella isolates
A comparison of antibiotic resistance patterns between integron-positive and
integron-negative Salmonella spp. isolates is provided in Figure 6. All Salmonella
isolates were susceptible to amikacin, gentamicin, kanamycin, streptomycin, ceftriaxone
and ciprofloxacin. In addition, all integron-negative isolates were also susceptible to
chloramphenicol. All integron-positive isolates were resistant to sulfamethoxazole.
Integron-positive isolates also showed a high percentage (55.6-66.7%) of resistance to
ampicillin,

chloramphenicol,

nalidixic

acid,

trimethoprim/sulfamethoxazone

and

tetracycline, whereas only 11.5% of those isolates were resistant to amoxicillin/clavulanic
acid, cephalothin, cefoxitin and ceftiofur. While a high percentage of resistance (51.560.6%) to ampicillin, sulfamethoxazole, amoxicillin/clavulanic acid, cephalothin,
cefoxitin, and ceftiofur was found in integron-negative isolates, less than 10% of those
isolates were resistant to nalidixic acid, trimetroprim/sulfamethoxazole and tetracycline.
Resistance to sulfamethoxazone, chloramphenicol, nalidixic acid, tetracycline, and
trimethoprim/sulfamethoxazole was more common in integron-positive isolates. In
contrast, resistance to amoxicillin/clavulanic acid, cephalothin, cefoxitin, and ceftiofur
was more frequent in integron-negative isolates (P<0.05).
A comparison between resistance frequencies of Salmonella isolates from
Thailand and the US is shown in Figure 7. Resistance to ampicillin and sulfamethoxazole
was found in Salmonella isolates from both countries, although no significant differences
were

noted

(P>0.05).

There

were

significant

differences

in

resistances

to

amoxicillin/clavulanic acid, cephalothin, cefoxitin, ceftiofur, chloramphenicol, nalidixic
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Figure 6. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative Salmonella spp. from chickens.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05).
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Figure 7. Frequency of resistance to 16 antimicrobials in Salmonella spp. of chicken
isolates from the US and Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05).
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acid, trimethoprim/sulfamethoxazole and tetracycline between Salmonella isolates from
Thailand and the US (P<0.01). Resistance to amoxicillin/clavulanic acid, cephalothin,
cefoxitin, and ceftiofur was found only in isolates from the US; in contrast, resistance to
chloramphenicol, nalidixic acid, trimethoprim/sulfamethoxazone and tetracycline was
found only in Thailand.
All Salmonella isolates were resistant to 1 to 6 antibiotics (Figure 8). Among 41
Salmonella isolates investigated, 8 resistance patterns were observed. Fifteen isolates
(36.6%) were found to have resistance to only sulfamethoxazole and appeared to be the
most common resistance pattern in Salmonella isolates. Thirteen isolates (31.0%)
demonstrated resistance to 6 antimicrobials with those being Aug-Amp-Fox-Tio-Cpl-Sul
and Amp-Chl-Nal-Sul-Tet-Sxt. Two patterns were found in both integron–negative and
integron-positive isolates with those being Aug-Amp-Fox-Tio-Cpl-Sul and Sul. Similar
to E. coli isolates, no common patterns were found among Salmonella isolates from
Thailand and the US (Table 6).
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Figure 8. Multiple antimicrobial resistance of Salmonella spp. isolates from chickens
A. Integron-positive and integron-negative isolates.
B. Isolates from the US and Thailand.
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Table 6. Antibiograms of Salmonella spp. isolates of chickens from the US and Thailand.
No. of isolate(s)
Pattern
No.
1
2
3
4
5
6
7
8

Antibiogram1

Aug-Amp-Fox-Tio-Cpl-Sul 2
Aug-Amp-Fox-Tio-Cpl
Amp-Chl-Nal-Sul-Tet-Sxt
Amp-Nal-Sul-Tet-Sxt
Amp-Nal
Amp
Nal
Sul 2

Integron

Location

Total

+

-

US

Thailand

(n=9)

(n=33)

(n=33)

(n=9)

(n=42)

1
0
5
0
0
0
0
3

7
10
0
1
1
1
1
12

8
10
0
0
0
0
0
15

0
0
5
1
1
1
1
0

8
10
5
1
1
1
1
15

1

Aug, Amoxicillin/Clavulanic Acid; Amp, Ampicillin; Fox, Cefoxitin; Tio, Ceftiofur;
Cpl, Cephalothin; Chl, Chloramphenicol; Nal, Nalidixic Acid; Sul, Sulfamethoxazole;
Tet, Tetracycline; Sxt, Trimethoprim/Sulfamethoxazole.
2
Resistance pattern found in both integron-positive and integron-negative isolates.
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P. mirabilis isolates
All 60 P. mirabilis isolates were susceptible to 4 of the test antibiotics, amikacin,
cefoxitin, ceftiofur and ceftriazone. In addition, all integron-negative isolates were also
susceptible to

ciprofloxacin.

All

integron-positive

isolates

were

resistant

to

sulfamethoxazole, which was higher than the 21.2% noted for integron-negative isolates
(P<0.001). A high percentage (45.5-97%) of resistance to tetracycline, ampicillin and
cephalothin was also found in both integron-negative and integron-positive isolates. In
contrast, less than 35% of integron-negative and integron-positive isolates were resistant
to gentamicin, kanamycin, streptomycin, amoxicillin/clavulanic acid, chloramphenicol,
nalidixic acid and trimethoprim/sulfamethoxazole (Figure 9).
A comparison between Thailand and the US is shown in Figure 10. All Thailand
and US isolates were susceptible to amikacin, cefoxitin, ceftiofur and ceftriazole, and all
US isolates were also susceptible to chloramphenicol and ciprofloxacin. Resistance to
nalidixic acid, trimethoprim/sulfamethoxazole, chloramphenicol, and streptomycin was
more common in Thailand compared to the US (P<0.05); whereas isolates from the US
showed a higher percentage of resistance to cephalothin (P<0.05).
The distribution of multiresistance among P. mirabilis isolates is shown in Figure
11. Overall, all P. mirabilis isolates from chickens were resistant to at least one antibiotic.
Integron-positive and -negative isolates were resistant to 2 to 8 and 1 to 8 antimicrobials,
respectively. Eighty-one percent of integron-positive isolates were resistant to at least
four antimicrobials; whereas, a lower percentage was found in integron-negative isolates
with 45% of those isolates demonstrated resistance to that number of antimicrobials.
119

*

100

Int +

90

Int -

% of resistant isolates

80
70
60
50
40
30
20
10

Te
t

t
Sx

l
Su

Na
l

Ci
p

Ch
l

Ax
o

T io

Fo
x

Cp
l

g
Au

Am
p

St r

n
Ka

n
Ge

Am
i

0

Antibiotics1,2

Figure 9. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative P. mirabilis from chickens.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05).
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Figure 10. Frequency of resistance to 16 antimicrobials in P. mirabilis of chicken
isolates from the US and Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within the same antibiotic with * differ (P<0.05).
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Figure 11. Multiple antimicrobial resistance of P. mirabilis isolates from chickens.
A. Integron-positive and integron-negative isolates.
B. Isolates from the US and Thailand.
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Proteus mirabilis isolates from both the US and Thailand were resistant to 1 to 8
antimicrobials. A large portion of P. mirabilis from Thailand tended to be resistant to a
higher number of antimicrobials than isolates from the US with over 50% of isolates from
Thailand demonstrating resistance to more than 5 antimicrobials; whereas only 17% of
isolates from the US were resistant to that number of antibiotics.
A total of 29 resistance patterns were noted among 60 P. mirabilis isolates.
Thirteen patterns were found in integron-positive and 17 patterns were found in integronnegative isolates. Four isolates were resistant to 8 antimicrobials with those being AugAmp-Cpl-Kan Gen-Str-Sul-Tet, Aug-Amp-Cpl-Nal-Str-Sul-Tet-Sxt, Amp-Chl-Kan-NalStr-Sul-Tet-Sxt, and Amp-Chl-Gen-Nal-Str-Sul-Tet-Sxt. Among 29 patterns, only one
antibiogram, Sul-Tet, was found in both integron-positive and integron-negative isolates.
In contrast to E. coli and Salmonella isolates, one pattern, resistance to tetracycline, was
found among isolates from Thailand and the US (Table 7).
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Table 7. Antibiograms of P. mirabilis isolates of chickens from the US and Thailand.
No. of isolate(s)
Pattern
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Antibiogram1

Aug-Amp-Cpl-Kan Gen-Str-Sul-Tet
Aug-Amp-Cpl-Nal-Str-Sul-Tet-Sxt
Aug-Amp-Cpl-Nal-Tet
Aug-Amp-Cpl-Sul-Tet
Aug-Amp-Cpl-Tet
Amp-Cpl-Nal-Tet
Amp-Cpl-Sul-Tet-Sxt
Amp-Cpl-Sul-Tet
Amp-Cpl-Sul-Sxt
Amp-Cpl-Tet
Amp-Chl-Kan-Nal-Str-Sul-Tet-Sxt
Amp-Chl-Gen-Nal-Str-Sul-Tet-Sxt
Amp-Nal-Sul-Tet-Sxt
Cpl-Nal-Tet
Cpl-Sul-Tet-Sxt
Cpl-Tet
Cpl
Chl-Cip-Nal-Sul-Tet-Sxt
Chl-Kan-Nal_Str-Sul-Tet-Sxt
Chl-Kan-Nal-Tet
Kan-Gen-Str-Sul-Tet
Kan-Gen-Sul-Tet
Gen-Nal-Str-Sul-Tet-Sxt
Gen-Str-Sul-Tet
Nal-Sul-Tet-Sxt
Nal-Sul-Tet
Nal-Tet
Sul-Tet 2
Tet 3

Integron

Location

Total

+

-

US

Thailand

(n=27)

(n=33)

(n=46)

(n=14)

(n=60)

1
0
0
1
0
0
3
7
1
0
1
0
1
0
0
0
0
2
0
0
1
1
0
2
0
2
0
4
0

0
1
2
0
4
1
0
0
0
6
0
1
0
1
1
1
1
0
1
1
0
0
1
0
1
0
1
1
8

1
0
2
1
4
1
3
7
1
6
0
0
0
1
1
1
1
0
0
0
1
1
0
2
0
0
0
5
7

0
1
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
2
1
1
0
0
1
0
1
2
1
0
1

1
1
2
1
4
1
3
7
1
6
1
1
1
1
1
1
1
2
1
1
1
1
1
2
1
2
1
5
8

1

Aug, Amoxicillin/Clavulanic Acid; Amp, Ampicillin; Cpl, Cephalothin; Chl,
Chloramphenicol; Cip, Ciprofloxacin; Gen, Gentamicin; Kan, Kanamycin; Nal, Nalidixic
Acid; Str, Streptomycin; Sul, Sulfamethoxazole; Tet, Tetracycline; Sxt,
Trimethoprim/Sulfamethoxazole.
2
Resistance pattern found in both integron-positive and integron-negative isolates.
3
Resistance pattern found in both Thailand and US isolates.
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IV. DISCUSSION
Prevalence of Bacterial isolates
In this study, we determined the prevalence of three bacteria: E. coli, Salmonella
spp., and P. mirabilis, in chickens from the US and Thailand. It was expected that the
prevalence of E. coli in fecal samples would be high, and our results showed that more
than 95% of chickens from both countries were found to carry E. coli. The prevalence of
E. coli in our results compares with that reported by Bywater et al. (9) who noted the
isolation rate for E. coli approached 100% in chickens from France, Netherlands,
Sweden, and the UK. In contrast to E. coli, we found a much lower prevalence of
Salmonella spp. in chickens, with only 3.3% of chickens from Thailand and 21.2% of
chickens in the US being positive for Salmonella. The difference in Salmonella
prevalence between countries may be due to differences in the methods of isolate
collection. While Salmonella isolates in the US were collected from killed chickens at a
slaughterhouse, Salmonella isolates from Thailand were isolated from live chickens on
farms. The stress caused by transportation of animals from farm to slaughterhouse has
been reported to result in increased Salmonella shedding (8, 44, 48). However, our results
from the US show a higher prevalence compared to that found in studies conducted in
Brazil and Europe. The study conducted in Brazil detected Salmonella in only 6.7% of
carcasses prior to evisceration (50). Similarly the European study noted that 7.1% of
chickens contained Salmonella (9). The prevalence of Salmonella in chickens from
southern Thailand in our study was comparable to that found by another study conducted
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in the northern part of Thailand, with that report indicating 4% of chickens carried
Salmonella (44).
P. mirabilis is a bacteria often found in farm environments and intestinal tracts of
both animals and humans. Although lacking the ability to cause disease in poultry, it can
cause opportunistic urinary tract infections in humans (56, 66). Although less studied
than E. coli and Salmonella, several recent studies have reported the presence of mobile
genetic elements involved in antibiotic resistance dissemination in P. mirabilis (2, 31,
59). We therefore included P. mirabilis in our study.

Prevalence of Class 1 Integrons
It is well known that class 1 integrons play an important role in dissemination of
antibiotic resistance in the Enterobacteriaceae. Our results show that class 1 integrons, as
indicated by the presence of intI1 gene, are widespread in enteric bacteria of broiler
chickens. More than 70% and 40% of E. coli isolated from Thailand and the US,
respectively, carried class 1 integrons. Bass et al. (7) noted that 63% of pathogenic E. coli
isolates obtained from diseased poultry were positive for the class 1 integron markers
intI1 and qacEΔ1. The prevalence of class 1 integrons in Salmonella isolates was lower
than that of E. coli in our study. Our results showed that only 48.1% and 0.5% of
Salmonella isolates from Thailand and the US, respectively, carried class 1 integrons.
Similar to our study, Diarrassouba et al. (16) noted a higher prevalence of class 1
integrons in E. coli isolates. That group studied the prevalence of class 1 integrons
(qacEΔ1-sul1) in 74 sorbitol negative E. coli and 62 Salmonella isolates from nine broiler
chicken farms in Canada and detected class 1 integron genes in 40% of sorbitol negative
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E. coli, however they were not detected in any Salmonella isolates. A low prevalence of
class 1 integrons was also noted in Salmonella isolates in other poultry varieties. Only 2
of 80 (2.5%) Salmonella isolates from turkeys at processing plants in the US carried class
1 integrons (42). Zhao et al. (65) noted a higher prevalence of class 1 integrons, with 43%
of 380 Salmonella isolates recovered from animal diagnostic samples (swine, turkeys,
cattle, chickens, and horses ) obtained from four state veterinary diagnostic laboratories
(AZ, NC, MO, and TN) between 2002 and 2003 carrying class 1 integrons. However, the
prevalence of class 1 integrons was not reported for each animal group. The higher
prevalence of class 1 integrons in these Salmonella may be due to their being isolated
from diseased animals, which may have been exposed to antimicrobial treatments more
frequently than healthy animals.
Our results show that 38.2% of P. mirabilis isolates from Thailand contained class
1 integrons and this was not different from the 29.9% of US isolates. Because of their
ability to harbor class 1 integrons, P. mirabilis may provide a reservoir for these
determinants and may account to some degree for rapid dissemination of antibiotic
resistance genes.
It is important to note, however, that while only 32.5, 75.4, and 82.9% of intI1positive E. coli, P. mirabilis, and Salmonella isolates from Thailand were found to carry
qacEΔ1 and sul1, almost all of the E. coli (96.8%), all P. mirabilis, and Salmonella intI1positive isolates from the US carried qacEΔ1 and sul1. In agreement with that found in
Thailand isolates in our study, van Essen-Zandbergen noted that only a subset of
Salmonella and E. coli isolates carrying intI1 are also carried the 3’ conserved sequence
(62). Sunde (57) reported that a high proportion of class 1 integrons found in E. coli
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lacked the sul1 gene. Additionally, Guerra et al. (24) found defective integrons which
lacked both qacEΔ1 and sul1, or only sul1, in some E. coli isolates from Germany,
suggesting that use of specific primers to detect conserved segments alone can produce
false negatives when those specific gene components are not present in otherwise
functional integrons.

Antibiotic Susceptibility
Antibiotic resistance was found in all bacterial isolates tested in this study. A high
proportion (86-100%) of tetracycline resistance was found in E. coli and P. mirabilis
from Thailand and the US and Salmonella spp. from Thailand. In agreement with our
study, several research groups from different countries also found a high level of
tetracycline resistance in broiler chickens. For example, Smith et al. (55) noted 97% of E.
coli isolated from farms that used antibiotics in northeast Georgia were resistant to
tetracycline. Mile et al. (41) found tetracycline resistance at a frequency of 82.4% in E.
coli isolates from Jamaica, Geornaras et al. (22) reported 90% of E. coli isolates from
South Africa were resistant to tetracycline, and Yang et al. (64) noted all E. coli isolated
from diseased chickens in China were also resistant to tetracycline. Asai et al. (6)
reported that resistance to both oxytetracycline and dihydrostreptomycin accounted for
94.0% of the resistance patterns in Salmonella enterica serotype Infantis isolates from
meat and broilers in Japan, and Diarrasouba et al. reported 75.8% of combined E. coli
and Salmonella isolates from Canada were resistant to tetracycline (16). The high
percentage of resistance to tetracycline may reflect the selection pressure caused by wide
use of these drugs in farm animals (26, 53). A high percentage of tetracycline resistance
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may also result from an ability of animals to serve as a reservoirs of tetracycline resistant
bacteria for a long periods of time, as indicated by the survey conducted in United
Kingdom in 1980, which found tetracycline-resistant E. coli in chickens and pigs 9 years
following a ban on tetracycline use as a feed additive (54).
When comparing the frequency of antibiotic resistance between integron-positive
and integron negative isolates, we found that integron-positive isolates were more likely
to be resistant to sulfamethoxazole than integron-negative isolates in all three types of
bacteria tested. This likely occurred because all integron-positive isolates contained sul1
as an integral part of the integron. Similar to our study, Shahada et al. (53) reported all of
the intI1-positive S. enterica serovar Infantis isolates collected were resistant to
sulfamethoxazole. In addition, integron-positive E. coli and Salmonella isolates were also
statistically more likely to be resistant to chloramphenicol compared to integron-negative
isolates. While this study did not aim to characterize specific gene cassettes incorporated
in the integrons, several research groups have reported cat and cml genes, responsible for
chloramphenicol resistance, as a gene cassette within the integron (17, 25, 28, 33, 39, 40,
46). This might explain the high prevalence of chloramphenicol resistance in integronpositive bacteria.
It should, however, be noted that the resistance phenotypes in our study were only
partially explained by the presence of integrons. In agreement with our study, a study of
the occurrence of integrons and antimicrobial resistance genes among Salmonella
enterica in Brazil revealed that integron-mediated resistance genes contributed to the
multiresistance phenotypes observed in the isolates; however, most resistance genes were
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located outside the integron structure as independent genes. Another researcher also
suggested that the genes might also be located on the same conjugative plasmid (46).
When comparing isolates from Thailand and the US, we found that resistance
patterns differed, with no common patterns occurring between each type of bacteria from
those two countries. All three types of bacteria from Thailand had a higher prevalence of
resistance to chloramphenicol, nalidixic acid, and trimethoprim/sulfamethoxazole than
isolates from the US. E. coli and Salmonella isolates from the US showed a statistically
greater prevalence of resistance to amoxicillin/clavulanic acid, cefoxitin, and ceftiofur
than those from Thailand. Salmonella and P. mirabilis isolates from the US demonstrated
a more frequent occurrence of resistance to cephalothin than isolates from Thailand. The
distribution of antimicrobial resistance phenotypes can be expected to reflect different
use patterns of antimicrobial agents (1, 21, 38).
Chloramphenicol was a popular veterinary product and was used particularly in
difficult disease cases. However, due to concerns over transfer of antibacterial resistance
in zoonotic pathogens, particularly in Salmonella, its use in animals has been restricted or
banned in many countries. Chloramphenicol cannot be used in food animals in the US
and Canada and can only be used as an eye ointment for small animals in the UK (26). In
Thailand, chloramphenicol has been banned from animal feeds since 1999 (4). Thus, the
prevalence of resistance to this antibiotic was noteworthy.
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V. CONCLUSIONS
Antimicrobial resistance genes and class 1 integrons are common in bacteria
associated with chickens in both Thailand and the US. While multi-antibiotic resistance
is associated with integrons, and specific multi-resistance patterns were often
characteristic of integron carriage, many multi-resistant isolates with a variety of
antibiograms also lacked class 1 integrons. Our work indicates that integrons and multiantibiotic resistant bacteria appear to be a significant aspect of microbial communities
associated with chickens.
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IN THE US AND THAILAND
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ABSTRACT
The objective of this study was to investigate the prevalence of class1 integrons
and antimicrobial resistance patterns in E. coli and Salmonella isolates of commercial
swine from the US and Thailand. In market pigs, class 1 integrons, as indicated by the
presence of intI1, were detected in 1,130 isolates (39.9%). Simultaneous presence of all
three conserved genes (intI1, qacEΔ1, and sul1) was found in 184 (6.5%) of the total of
2,833 isolates. The prevalence of class 1 integrons in E. coli and Salmonella spp. was
found to differ with isolate origin (P<0.001). In both types of bacteria, class 1 integrons
were more prevalent in isolates from Thailand compared with the US (68.8 and 25.9% for
E. coli isolates, 37.8 and 10.3% for Salmonella spp. isolates from Thailand and the US,
respectively). In sows, 46% of 1,420 bacterial isolates were found to carry the intI1 gene;
however only 4.8% of these bacteria carried all three conserved genes. Similarly, for
market pigs the prevalence of class 1 integrons in Salmonella isolates was found to differ
with isolate origin (P<0.001). Approximately 72% of Salmonella isolates from sows in
Thailand contained class 1 integrons, which was higher than the 29.8% of the isolates
from US. Among E. coli isolates, 64.8% of isolates from Thailand carried integrons;
however this was not different from the US (56.6%) (P=0.08) Most isolates were multiantibiotic resistant. A high proportion of isolates demonstrated resistance to tetracycline
(95.8%), sulfamethoxazole (70.8%), streptomycin (55.7%), and ampicillin (52.6%).
Integron-positive-isolates tended to be resistant to a higher number of antibiotics than
integron-negative isolates. In addition, resistance to streptomycin, sulfamethoxazole, and
trimethoprim/sulfamethoxazole is more common in integron-positive isolates than
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integron-negative isolates. Among 113 antibiotic resistance patterns found in antibiotic
susceptibility tests in integron-positive and integron-negative, 11 patterns (9.7%) were
found in both integron positive and integron negative isolates. Among 39 antibiotic
resistance patterns found in Thailand and the US, only 2 patterns (5.1%) were found in
both countries. These results indicate that class 1 integrons are common in commensal
and foodborne bacteria in swine, and that some, but not all, antibiotic resistances in those
isolates are associated with the presence of class 1 integrons.
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I. INTRODUCTION
Food animals are often exposed to antimicrobials to treat and prevent infectious
disease or to promote growth (33). Antimicrobial usage in food animals provides
selection pressure that favors an increase of antimicrobial resistant bacteria (17, 23, 28,
29). Antimicrobial resistance has emerged not only in commensal bacteria and bacterial
pathogens of animals but also in zoonotic enteropathogens (33). Resistant bacteria from
animals can infect humans by direct contact and also via consumption of food products of
animal origin (53, 56). These resistant bacteria can colonize humans and/or transfer their
resistance genes to other bacteria of humans, which can result in treatment failure as a
consequence of antimicrobial resistance (54).
Integrons are genetic elements that mediate integration of antibiotic resistance
genes through site specific recombination and convert them into functional genes (9, 15,
19, 30, 43). More than 70 different genes imparting resistance to most classes of
antimicrobials have been found as gene cassettes in the central region of different
integrons from diverse bacteria (44). Moreover, these genetic elements can incorporate
several resistance genes, allowing them to transfer as a single gene. As many as seven
gene cassettes have been found within an integron (51). Integrons are often found to be
carried on mobile elements such as plasmids and transposons; therefore, integrons are
believed to play a major role in the rapid dissemination of multi-drug resistance among
bacteria (36). Four different classes of integrons have been identified based on variations
in sequence of primary elements, gene cassettes, and associations with transposons (2, 3,
10, 14, 15, 41, 46). Class 1 integrons are the most common and widely distributed type
(5, 14, 38).
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The U.S. and Thailand, while occupying very diverse geographic regions, share
many commonalities in livestock production practices. Swine production tends to be
intensive, with closed confinement, high biosecurity and similar high production genetic
lines. Feed-based antibiotics are commonly used in both countries, although some
differences occur in drugs of choice and/or availability. A comparison of class 1 integron
prevalence and antibiotic resistance gene patterns of E. coli and Salmonella spp. between
these two countries may provide information regarding global implications of agricultural
use of antibiotics with relevance to antibiotic resistance.
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II. MATERIALS AND METHODS
Bacterial Isolates
A total of 2,820 E. coli and Salmonella spp. isolates were collected via fecal swab
from 524 market pigs from 3 farms; and 120 sows from 3 farms at abattoirs in the US. In
addition, 1,433 E. coli and Salmonella spp. isolates were collected from 436 market pigs
from 6 farms and 130 sows from 2 farms in southern Thailand. All bacterial collections in
Thailand took place in the southern Thailand during the period of May 2003 to August
2004, whereas bacterial collections from the US took place in Tennessee during the
period of November 2004 to October 2005. All isolates were recovered from fecal swabs
by standard microbiological procedures. The primary isolation method for E. coli has
been described previously (31). For Salmonella isolation, fecal swabs were first enriched
in selective tetrathionate broth (Difco, Sparks, MD) and incubated at 41.5+1ºC for 18-24
h. Enriched broth cultures were then plated on Xylose Lysine Tergitol 4 agar (XLT4;
Difco) for selective culture. Plates were incubated at 37+1ºC and examined after 18-24 h.
Presumptive Salmonella colonies were subcultured and then plated again, and identity
was confirmed with API 20E strips according to the manufacturer’s specification
(bioMérieux Vitek, Inc., Hazelwood, MO). Up to 6 colonies of each bacterial type were
selected for analysis. Bacterial cultures were maintained at -80°C in 10% glycerol until
analysis.
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Multiplex PCR (MP-PCR)
Integron harboring isolates were detected using a MP-PCR targeting three
conserved sequences of class 1 integrons, intI1, qacEΔ1, and sul1 (13). Primer pairs were
manufactured by Operon, Inc. (Alameda, CA) (Table 1). Total DNA was prepared by
boiling overnight cultures in 2YT broth (Difco) in an equal volume of 0.2% (wt/vol)
Triton X-100 (Mallinckrodt, Paris, KY) for 5 min (24). Boiled cultures were cooled on
ice for 5 min and used immediately for PCR. PCR reagents, excluding template DNA,
were combined in a master mix prior to aliquoting. The final reaction volumes for each
aliquot included: 1) 1 μL of each primer pair (50 pmol (each primer) μL-1); 2) 1 μL of
Taq DNA polymerase (0.5U μL–1; Promega, Madison, WI); 3) 10 μL reaction buffer
(12.5mM MgCl2, pH 8.5; Invitrogen, Carlsbad, CA); 4) 5 μL dNTPs solution (2.5mM of
each dNTP, pH 8.0; Invitrogen); and 5) 32 μL sterile H2O. Sample DNA (1 μL) was then
added to each aliquot. Reactions were conducted in a Mastercyler Gradient thermocycler
(Eppendorf, Westbury, NJ) with the following conditions: 1) 1 cycle of 94°C for 4 min;
2) 10 "touchdown" cycles of 94°C for 1 min, 65°C for 30s (decreasing 1°C/cycle), 70°C
for 2 min; 3) 24 cycles of 94°C for 1 min, 55°C for 30s, 70°C for 2 min; and 4) 1 final
cycle of 70°C for 5 min. Salmonella Typhimurium DT104 known to contain two class 1
integrons (23) was used as a positive control. A blank containing only PCR reagents and
Triton X-100 was used as a negative control. Reaction products were separated by
conventional electrophoresis in 1.5% agarose and stained with ethidium bromide for
visualization (Figure 1). Prevalence of class 1 integrons was based on the presence of the
IntI1 gene.
145

The integron prevalence in each bacterial species was compared between
Thailand and the US using the freq procedure of SAS (SAS 8.2, SAS Institute Inc, Cary,
NC) Comparisons were made using the Fisher's two-sided exact tests. Differences were
considered significant at P < 0.05.
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Table 1. Primer pairs used in MP-PCR.
Target
intI1
sul1
qacEΔ1

Sequence (5’ to 3’)
(F)
(R)
(F)
(R)
(F)
(R)

GGTTCGAATGTCGTAACCGC
ACGCCCTTGAGCGGAAGTATC
ATCAGACGTCGTGGATGTCG
CGAAGAACCGCACAATCTCG
GAGGGCTTTACTAAGCTTGC
ATACCTACAAAGCCCCACGC

PCR product
(bp)
248
346
200
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1

2

3

4

5

6

7

8

9

10

sul1 (346bp)
IntI1 (248bp)

qacEΔ1 (200bp)

Figure 1. Multiplex PCR detecting class 1 integrons gene sequence.
Lane 1; 100 bp DNA ladders; Lane 2 -7 wild type isolates; lane 8; negative control; and
lane 9; Salmonella enterica Typhimurium DT104 (positive control).
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Antibiotic Susceptibility Testing
Antibiotic MICs were determined for subsets of each bacterial type using the
National Antimicrobial Resistance Monitoring System (NARMS) microdilution sensititre
plates, CMV7CNCD, (Sentititre, Trek Diagnostic System Inc., Cleveland, Ohio)
according to Clinical and Laboratory Standards Institute (CLSI), (formerly National
Committee on Clinical Laboratory Standards, NCCLS) broth microdilution guidelines.
Escherichia coli ATCC 25922 was used as a reference strain. The isolates were tested for
resistance

to

16

antibacterials

or

antibacterial

combinations

that

included

amoxicillin/clavulanic acid (Aug), ampicillin (Amp), ciprofloxacin (Cip), cefoxitin (Fox),
ceftiofur (Tio), ceftriaxone (Axo), cephalothin (Cpl), chloramphenicol (Chl), amikacin
(Ami), gentamicin (Gen), kanamycin (Kan), nalidixic acid (Nal), streptomycin (Str),
sulfamethoxazole (Sul), tetracycline (Tet), and trimethoprim/sulfamethoxazole (Sxt).
The CMV7CNCD plate layout is shown in Figure 2. Results were interpreted using CLSI
guidelines for broth microdilution methods for veterinary E. coli (Table 2). In the
phenotypic analysis, isolates with intermediate MICs were not considered as resistant.
The frequency of antibiotic resistance in integron-positive isolates was compared
to that of integron-negative isolates and frequency of antibiotic resistance in isolates from
Thailand was compared to the US using the Analysis and Statcalc programs of the Epi
InfoTM version 3.4.1 software package from the Center for Disease Control and
Prevention (6). Comparisons were made using the Fisher's two-sided exact tests.
Differences were considered significant at P<0.05.
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8
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4
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2
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1
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0.5
Ami
4
Ami
2

Ami
1
Ami
0.5
Chl
32
Chl
16
Chl
8
Chl
4
Chl
2
Tet
32

Tet
16
Tet
8
Tet
4
Axo
64
Axo
32
Axo
16
Axo
8
Axo
4

Axo
2
Axo
1
Axo
0.5
Axo
0.25
Aug
32/16
Aug
16/8
Aug
8/4
Aug
4/2

Aug
2/1
Aug
1/0.5
Cip
4
Cip
2
Cip
1
Cip
0.5
Cip
0.25
Cip
0.12

Cip
0.06
Cip
0.03
Cip
0.015
Gen
16
Gen
8
Gen
4
Gen
2
Gen
1

Gen
0.5
Gen
0.25
Nal
32
Nal
16
Nal
8
Nal
4
Nal
2
Nal
1

Nal
0.5
Tio
8
Tio
4
Tio
2
Tio
1
Tio
0.5
Tio
0.25
Tio
0.12

Sul
512
Sul
256
Sul
128
Sul
64
Sul
32
Sul
16
Sxt
4/76
Sxt
2/38

Sxt
1/19
Sxt
0.5/9.5
Sxt
0.25/4.75
Sxt
0.12/2.38
Cpl
32
Cpl
16
Cpl
8
Cpl
4

Cpl
2
Kan
64
Kan
32
Kan
16
Kan
8
Amp
32
Amp
16
Amp
8

Amp
4
Amp
2
Amp
1
Str
64
Str
32
Pos
Pos
Pos

Figure 2. Sensititre non-fastidious Gram negative plate (CMV7CNCD) format.
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline;
Pos, growth control wells.
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Table 2. Minimum Inhibitory Concentration (MIC) breakpoint. 1
Drugs
Aminoglycoside
Amikacin (Ami)
Gentamicin (Gen)
Kanamycin (Kan)
Streptomycin (Str) 2
β-Lactams
Ampicillin (Amp)
Amoxicillin/Clavulanic acid (Aug)
Cephalothin (Cpl)
Cefoxitin (Fox)
Ceftiofur (Tio)
Ceftriaxone (Axo)
Chloramphenicol (Chl)
Quinolone
Ciprofloxacin (Cip)
Nalidixic Acid (Nal)
Sulfonamides
Sulfamethoxazole (Sul)
Trimethoprim/Sulfamethoxazole (Sxt)
Tetracycline (Tet)

Susceptible
(μg/ml)

Intermediate
(μg/ml)

Resistant
(μg/ml)

≤ 16
≤4
≤ 16
≤ 32

32
8
32

≥ 64
≥ 16
≥ 64
≥ 64

≤8
≤ 8/4
≤8
≤8
≤2
≤8
≤8

16
16/8
16
16
4
16,32
16

≤1
≤ 16

2

≤ 256
≤ 2/38
≤4

8

≥ 32
≥ 32/16
≥ 32
≥ 32
≥8
≥ 64
≥ 32
≥4
≥ 32
≥ 512
≥ 4/76
≥ 16

1

MICs determined via microdilution broth methods in accordance with CLSI standards
(7, 8).
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III. RESULTS
Prevalence of Bacterial Isolates
The prevalence of E. coli isolates from swine was high in both countries and both
types of swine with all of market pigs and sows from the US and 82.3% and 97.4% of
market pigs and sows, respectively from Thailand were found to carry E. coli (Table 3).
However, the prevalence of Salmonella spp. in swine was considerably lower than that of
E. coli. The prevalence of Salmonella was higher in sows from the US, with 60.9% of
sows found to carry Salmonella, whereas that organism was detected in only 8.5% of
sows in Thailand. A similar prevalence of Salmonella was found in market pigs from
Thailand and the US with 3.4% and 5.7% of market pigs from Thailand and the US,
respectively, carrying these bacteria.
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Table 3. Prevalence of E. coli and Salmonella from market pigs in the US and Thailand.

Type of
swine
Market pig

Countries
US

Thailand

Sow

US

Thailand

Farm

# of
animals
sampled

# of animals carrying bacteria (%)
E. coli

Salmonella

US-A
US-B
US-C
Total
TH-A
TH-B
TH-C
TH-D
TH-E
TH-F
Total

124
200
200
524
110
176
10
10
10
120
436

124 (100)
200 (100)
200 (100)
524 (100)
94 (85.5)
151 (85.8)
10 (100)
10 (100)
10 (100)
84 (100)
359 (82.3)

7 (5.6)
4 (2.0)
19 (9.5)
30 (5.7)
8 (7.3)
4 (2.6)
0 (0)
2 (20.0)
0 (0)
1 (1.2)
15 (3.4)

US-D
US-E
US-F
Total
TH-C
TH-F
Total

60
48
12

60 (100)
48 (100)
12 (100)
120 (100)
100 (100)
25 (83.3)
125 (97.4)

35 (58.3)
32 (66.7)
6 (50.0)
73 (60.9)
10 (10.0)
1 (3.3)
11 (8.5)

120
100
30
130
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Prevalence of Class 1 Integrons
Prevalence of class 1 integrons in E. coli and Salmonella spp. in market pigs and
sows from Thailand and the US is shown in Table 4. In market pigs, class 1 integrons, as
indicated by the presence of intI1, were detected in 1,130 isolates (39.9%). Simultaneous
presence of all three conserved genes (intI1, qacEΔ1, and sulI1) was found in 184 (6.5%)
of the total of 2,833 isolates.

The prevalence of class 1 integrons in E. coli and

Salmonella spp. was found to be associated with isolate origin (P<0.001). In both types of
bacteria, class 1 integrons were more prevalent in isolates from Thailand compared with
the US (68.8% and 25.9% for E. coli isolates, 37.8% and 10.3% for Salmonella spp.
isolates from Thailand and the US, respectively). The prevalence of integrons across
farms in both E. coli and Salmonella spp. isolates differed (P<0.001) (data not shown)
In sows, forty-six percent of 1,420 bacterial isolates were found to carry intI1
gene; however only 4.8% of these bacteria carried all three conserved genes. Similarly,
for market pigs the prevalence of class 1 integrons in Salmonella isolates was found to be
associated with isolate origin (P<0.001). Approximately 72% of Salmonella isolates from
Thailand contained class 1 integrons, which was higher than the 29.8% of the isolates
from US. Among E. coli isolates, 64.8% of isolates from Thailand carried integrons;
however, this was not different from the US (56.6%) (P=0.08). The prevalence of
integrons across farms in both E. coli and Salmonella isolates also differed (P<0.01) (data
not shown)
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Table 4. Prevalence of integrons and integron component genes in bacteria of pigs from
the US and Thailand. 1

Type of swine
Market Pigs

No. of isolates
No. of isolates
No.(%) carrying
- IntI1 (I)
- All 3 conserved genes
(I,Q,S)

Sows

No. of isolates
No.(%) carrying
- IntI1 (I)
- All 3 conserved genes
(I,Q,S)

Salmonella spp.

E. coli
The US

Thailand

The US

Thailand

1,569

963

193

108

406
(25.9)b
102
(6.5)a

663
(68.8)a
49
(5.1)a

20
(10.3)b
0
(0.0)b

41
(37.8)a
33
(30.6)a

360

279

698

83

204
(56.6)a
11
(3.2)a

181
(64.8)a
0
(0.0)b

208
(29.8)b
15
(2.2)a

59
(71.7)a
5
(6.4)a

1

Results are reported as numbers and percentage of bacteria carrying integrons and genes
associated with integrons, as determined by multiplex PCR. I, intI1; Q, qacEΔ1; S, sul1.
a,b
Values within the same bacteria and row not sharing like superscripts differ (P<0.05.)
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Antibiotic Susceptibility
E. coli isolates
A comparison of antibiotic resistance prevalence between integron-positive and
integron-negative E. coli isolates from market pigs is provided in Figure 3. All integronnegative E. coli were susceptible to amikacin, ceftiofur, amoxicillin/clavulanic acid,
cefoxitin, ceftriaxone, and ciprofloxacin. In contrast, the only drug to which all integronpositive isolates were susceptible was cefoxitin. All integron-positive isolates were
resistant to tetracycline. Integron-positive isolates also showed a high percentage (4590%) of resistance to kanamycin, ampicillin, streptomycin, and sulfamethoxazole;
whereas less than 30% of these isolates were resistant to the rest of antibiotics. Similar to
integron-positive isolates, a high proportion (97.5%) of integron-negative isolates were
resistant to tetracycline. Resistance to gentamicin, kanamycin, ampicillin ciprofloxacin,
streptomycin, sulfamethoxazone, trimethoprim/sulfamethoxazone, and tetracycline was
more common in integron-positive isolates (P<0.05).
A comparison between resistance frequencies of E. coli isolates from market pigs
of Thailand and the US is shown in Figure 4. While resistance to amikacin, ceftiofur,
ceftriaxone, and ciprofloxacin was found only in isolates from Thailand, resistance to
amoxicillin/clavulanic acid was found only in the US. Resistance to kanamycin,
streptomycin, sulfamethoxazole, and tetracycline was found in E. coli isolates in both
countries, however no significant differences were noted (P>0.05). There were significant
differences in resistance to gentamicin, ampicillin, cephalothin, chloramphenicol,
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Figure 3. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative E. coli from market pigs.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within antibiotic with * differ (P<0.05).
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Figure 4. Frequency of resistance to 16 antimicrobials in E. coli of market pigs from
the US and Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within antibiotic with * differ (P<0.05).
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ciprofloxacin, nalidixic acid, and sulfamethoxazole with resistance being generally more
common in isolates from Thailand (P<0.01).
The distribution of multiresistance among E. coli isolates from market pigs is
shown in Figure 5. While integron-positive isolates were resistant to 1 to 10 antibiotics,
four out of sixty integron-negative isolates (6.7%) were susceptible to all 16 antibiotics
tested and the rest were resistant to 1 to 7 antibiotics. Ninety percent of integron-positive
isolates were resistant to at least three antibiotics; whereas, a lower percentage was found
in integron-negative isolates, with 51.7% of those isolates demonstrating resistance to
that number of antimicrobials. A large proportion of E. coli isolates from Thailand tended
to be resistant to a higher number of antimicrobials than isolates from the US, with over
75% of isolates from Thailand demonstrating resistance to 4 to 10 antibiotics; whereas
only 27.5% of isolates from the US were resistant to 4 to 7 antibiotics.
A total of 58 patterns were observed among 120 E. coli isolates from market pigs.
The most frequent pattern was resistance to 3 antimicrobials, Str-Sul-Tet, which was
found in 35% of isolates. Three isolates (5.0%) exhibited resistance to the highest number
of antimicrobials (10) with those being Ami-Amp-Chl-Kan-Gen-Nal-Str-Sul-Tet-Sxt and
Amp-Cpl-Chl-Kan-Gen-Nal-Str-Sul-Tet-Sxt. Among the 58 patterns, seven were found
in both integron-positive and integron-negative isolates. Furthermore, two resistance
patterns (Amp-Str-Tet and Amp-Tet) were found in both countries (Table 5).
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Figure 5. Multiple antimicrobial resistance of E. coli from market pigs.
A. Integron-positive and integron-negative isolates.
B. Isolates from the US and Thailand.
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Table 5. Antibiograms of E. coli isolates of market pigs from the US and Thailand.
No. of isolate(s)
Pattern
No.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Antibiogram1

Ami-Amp-Cpl-Chl-Kan-Str-SulTet-Sxt
Ami-Amp-Chl-Kan-Gen-Nal-StrSul-Tet-Sxt
Aug-Amp-Cpl-Kan-Str-Sul-Tet
Amp-Tio-Cip-Str-Sul-Tet-Sxt
Amp-Axo-Cip-Nal-Sul-Tet-Sxt
Amp-Cpl-Chl-Kan-Gen-Nal-StrSul-Tet-Sxt
Amp-Cpl-Chl-Kan-Gen-Str-SulTet-Sxt
Amp-Cpl-Chl-Kan-Str-Sul-Tet-Sxt
Amp-Cpl-Chl-Sul-Tet
Amp-Cpl-Nal-Str-Sul-Tet
Amp-Cpl-Tet
Amp-Chl-Cip-Nal-Str-Sul-Tet-Sxt
Amp-Chl-Kan-Gen-Nal-Str-SulTet-Sxt
Amp-Chl-Kan-Gen-Str-Sul-TetSxt
Amp-Chl-Kan-Sul-Tet 2
Amp-Chl-Gen-Nal-Sul-Tet-Sxt
Amp-Chl-Gen-Str-Sul-Tet-Sxt
Amp-Chl-Str-Sul-Tet-Sxt
Amp-Chl-Str-Sul-Tet
Amp-Chl-Str-Tet-Sxt
Amp-Chl-Sul-Tet
Amp-Chl-Tet
Amp-Cip-Nal-Str-Sul-Tet-Sxt
Amp-Kan-Gen-Nal-Str-Sul-TetSxt
Amp-Kan-Gen-Str-Sul-Tet
Amp-Kan-Str-Sul-Tet
Amp-Kan-Sul-Tet
Amp-Nal-Sul-Tet
Amp-Str-Sul-Tet-Sxt

Integron

Location

Total

+

-

US

Thailand

(n=60)

(n=60)

(n=80)

(n=40)

(n=120)

1

0

0

1

1

1

0

0

1

1

1
1
1
2

0
0
0
0

1
0
0
0

0
1
1
2

1
1
1
2

1

0

0

1

1

1
0
1
1
3
1

0
1
0
0
0
0

0
1
0
1
0
0

1
0
1
0
3
1

1
1
1
1
3
1

2

0

0

2

2

1
0
1
1
1
0
0
0
1
2

1
1
0
0
0
1
3
1
0
0

2
0
0
0
1
0
3
0
0
0

0
1
1
1
0
1
0
1
1
2

2
1
1
1
1
1
3
1
1
2

3
1
0
0
0

0
0
1
1
1

3
1
1
0
1

0
0
0
1
0

3
1
1
1
1
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Table 5. (continued) Antibiograms of E. coli isolates of market pigs from the US and
Thailand.
No. of isolate(s)
Pattern
No.
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58

Antibiogram1

Amp-Str-Tet 3
Amp-Sul-Tet
Amp-Tet 3
Cph-Chl-Tet
Cpl-Gen-Nal-Tet
Cpl-Tet
Chl-Kan-Sul-Tet-Sxt
Chl-Nal
Chl-Str-Sul-Tet
Chl-Sul-Tet-Sxt
Chl-Tet
Kan-Nal-Str-Sul-Tet-Sxt
Kan-Nal-Sul-Tet
Kan-Str-Sul-Tet-Sxt
Kan-Str-Sul-Tet 2
Kan-Str-Tet 2
Kan-Sul-Tet
Kan-Tet 2
Gen-Nal-Sul-Tet
Gen-Str-Sul-Tet
Gen-Str-Tet
Nal-Sul-Tet-Sxt
Nal-Sul-Tet
Str-Sul-Tet-Sxt
Str-Sul-Tet
Str-Tet 2
Sul-Tet 2
Tet 2
None

Integron

Location

Total

+

-

US

Thailand

(n=45)

(n=45)

(n=70)

(n=20)

(n=90)

0
2
0
0
0
0
2
0
0
0
0
1
0
1
1
2
2
1
0
1
0
0
0
0
14
1
3
1
0

6
0
3
1
1
1
0
1
1
1
1
0
1
0
1
2
0
3
1
0
1
1
1
2
0
2
3
11
4

5
2
1
0
0
0
2
0
0
0
0
1
1
1
2
4
2
4
0
1
0
0
0
0
14
3
6
12
4

1
0
2
1
1
1
0
1
1
1
1
0
0
0
0
0
0
0
1
0
1
1
1
2
0
0
0
0
0

6
2
3
1
1
1
2
1
1
1
1
1
1
1
2
4
2
4
1
1
1
1
1
2
14
3
6
12
4

1

Ami, Amikacin; Aug, Amoxicillin/Clavulanic Acid; Amp, Ampicillin; Tio, Ceftiofur;
Axo, Ceftriaxone; Cpl, Cephalothin; Chl, Chloramphenicol; Cip, Ciprofloxacin; Gen,
Gentamicin; Kan, Kanamycin; Nal, Nalidixic Acid; Str, Streptomycin; Sul,
Sulfamethoxazole; Tet, Tetracycline; Sxt, Trimethoprim/Sulfamethoxazole.
2
Resistance pattern found in both integron-positive and integron-negative isolates.
3
Resistance pattern found in both Thailand and the US.
162

No E. coli isolates from sows in Thailand carried all three genes, which
prohibited a comparison between Thailand and the US. As a result, only integron-positive
and –negative isolates from the US were used for the comparison.
All E. coli isolates from sows in the US were susceptible to at least half of the
antibiotics tested in this study, with those being amikacin, amoxicillin/clavulanic acid,
cephalothin, cefoxitin, ceftiofur, ceftriaxone, ciprofloxacin, and nalidixic acid. In
contrast, all E. coli isolates were resistant to tetracycline. All integron-positive isolates
were resistant to streptomycin, ampicillin, sulfamethoxazole, and tetracycline. Integronpositive isolates also demonstrated a high percentage of resistance to gentamicin (90.9%),
kanamycin (90.9%), trimethoprim/sulfamethoxazole (72.7%), and chloramphenicol
(54.5%). Integron-negative isolates demonstrated a high percentage of resistance to
sulfamethoxazole (72.7%), ampicillin (63.6%), and streptomycin (54.5%). Resistance to
gentamicin, kanamycin, streptomycin, ampicillin, trimethoprim/sulfamethoxazole and
chloramphenicol was more common in integron–positive isolates (P<0.05) (Figure 6).
There was similarity between isolates from market pigs and isolates from sows,
with integron-positive E. coli isolates from sows tending to be more resistant to a higher
number of antimicrobials than integron-negative isolates. Integron-positive isolates
demonstrated resistance to 5 to 8 antibiotics; whereas integron-negative isolates
demonstrated resistance to 1 to 7 antibiotics (Figure 7).
Among 22 E. coli isolates investigated from sows in the US, 13 resistance
patterns were observed. The pattern, Amp-Chl-Kan-Gen-Str-Sul-Tet-Sxt, was found in
five isolates (4.5%). This pattern not only represented resistance to the highest number of
antibiotics but it was also the most common resistance pattern in E. coli isolates.
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Figure 6. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative E. coli of sows from the US.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within antibiotic with * differ (P<0.05).
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Figure 7. Percentage of integron-positive and integron-negative E. coli isolates from
sows in the US demonstrating resistance to various numbers of antibiotics.
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Only one pattern, Amp-Chl-Kan-Gen-Str-Sul-Tet, was found in both integron-positive
and integron-negative isolates (Table 6).
Salmonella isolates
In contrast to E. coli isolates from sows, Salmonella isolates which carried all 3
class 1 integron conserved genes were only found in market pigs from Thailand.
Therefore, only Thailand isolates were used for the comparison of antibiotic
susceptibility tests between integron-positive and –negative isolates.
A comparison of the prevalence of antibiotic resistance between integron-positive
and integron-negative Salmonella spp. isolates of market pigs from Thailand is given in
Figure 8. All integron-positive and -negative isolates were susceptible to amikacin,
amoxicillin/clavulanic

acid,

cephalothin,

cefoxitin,

ceftiofur,

ceftriaxone

and

ciprofloxacin. The highest percentage of resistance in integron-positive Salmonella
isolates was found to sulfamethoxazole (100%), followed by tetracycline (93.3%),
streptomycin (80.0%), nalidixic acid (73.3%), trimethoprim/sulfamethoxazole (73.3%)
ampicillin (66.7%), kanamycin (53.3%) and gentamicin (40.0%); whereas 86.7, 66.7,
53.3, 40.0, 33.3, 26.7, 26.7, and 20.0% of integron-negative isolates showed resistance to
tetracycline, sulfamethoxazole, nalidixic acid, ampicillin, kanamycin, gentamicin,
chloramphenicol,

trimethoprim/sulfamethoxazole

and

streptomycin,

respectively.

Resistance to streptomycin, chloramphenicol, sulfamethoxazole and combination of
trimethoprim and sulfamethoxazole was more common in integron–positive isolates
(P<0.05).
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Table 6. Antibiograms of E. coli isolates of sows from the US.
No. of isolate(s)
Pattern
No.
1
2
3
4
5
6
7
8
9
10
11
12
13

Antibiogram1

Amp-Chl-Kan-Gen-Str-Sul-Tet-Sxt
Amp-Chl-Kan-Gen-Str-Sul-Tet 2
Amp-Kan-Gen-Str-Sul-Tet-Sxt
Amp-Kan-Gen-Str-Sul-Tet
Amp-Kan-Str-Sul-Tet
Amp-Kan-Tet
Amp-Gen-Str-Sul-Tet
Amp-Str-Sul-Tet-Sxt
Amp-Str-Sul-Tet
Amp-Sul-Tet
Str-Sul-Tet
Sul-Tet
Tet

Integron

Total

+

-

(n=11)

(n=11)

(n=22)

5
1
3
0
1
0
1
0
0
0
0
0
0

0
1
0
2
0
1
0
1
1
1
1
1
2

5
2
3
2
1
1
1
1
1
1
1
1
2

1

Amp, Ampicillin; Chl, Chloramphenicol; Kan, Kanamycin; Gen, Gentamycin; Str,
Streptomycin; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet,
Tetracycline.
2
Resistance pattern found in both integron-positive and integron-negative isolates.
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Figure 8. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative Salmonella spp. of market pigs from Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within antibiotic with * differ (P<0.05).
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In agreement with E. coli isolates, integron-positive Salmonella isolates from
market pigs from Thailand tended to be more resistant to a higher number of antibiotics
than integron-negative isolates, with integron-positive isolates showing resistance to 3 to
9 antibiotics; whereas integron-negative isolates demonstrated resistance to 1 to 8
antibiotics (Figure 9).
There was a wide variety of resistance patterns found in Salmonella isolates from
market pigs, with a total of 26 patterns being observed among 30 Salmonella isolates.
Only 4 patterns were found in more than one isolate, with those being Amp-Chl-KanGen-Nal-Str-Sul-Tet-Sxt, Amp-Kan-Gen-Nal-Sul-Tet, Chl-Kan-Nal-Str-Sul-Tet-Sxt, and
Tet. There was no common pattern found in both integron-positive and –negative
Salmonella isolates from market pigs in Thailand (Table 7).
All 20 integron-positive and integron-negative Salmonella isolates from sows
were

susceptible

to

amoxicillin/clavulanic

the
acid,

same

7

antibiotics,

cephalothin,

with

cefoxitin,

those

being

ceftiofur,

amikacin,

ceftriazole

and

ciprofloxacin. All integron-positive isolates were resistant to 6 antibiotics, kanamycin,
streptomycin,

ampicillin,

trimethoprim/sulfamethoxazole,

tetracycline,

and

sulfamethoxazole, whereas the only drug to which all integron-negative isolates were
only resistant was tetracycline. A high percentage of resistance to gentamicin (80.0%),
nalidixic acid (70.0%), and chloramphenicol (60.0%) was also noted in integron-positive
isolates. Seventy percent of integron-negative isolates were resistant to ampicillin and
sulfamethoxazole. Up to 30% of integron-negative isolates were resistant to gentamicin,
kanamycin, streptomycin, chloramphenicol, trimethoprim/sulfamethoxazole and nalidixic
acid. Resistance to gentamicin, kanamycin, streptomycin, nalidixic acid, and
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Figure 9. Multiple antimicrobial resistance of integron-positive and integronnegative Salmonella isolates of market pigs from Thailand.
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Table 7. Antibiograms of Salmonella spp. isolates of market pigs from Thailand.
No. of isolate(s)
Pattern
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

Antibiogram1

Amp-Chl-Kan-Gen-Nal-Str-Sul-Tet-Sxt
Amp-Chl-Kan-Gen-Nal-Str-Sul-Tet
Amp-Chl-Kan-Gen-Str-Sul-Tet-Sxt
Amp-Chl-Kan-Nal-Str-Sul
Amp-Chl-Gen-Nal-Sul-Tet-Sxt
Amp-Chl-Nal-Str-Sul-Tet-Sxt
Amp-Chl-Nal-Sul-Sxt
Amp-Kan-Gen-Nal-Str-Sul-Tet-Sxt
Amp-Kan-Gen-Nal-Sul-Tet
Amp-Kan-Sul-Tet
Amp-Gen-Str-Sul-Tet-Sxt
Amp-Nal-Tet
Amp-Str-Sul-Tet
Amp-Sul
Chl-Kan-Gen-Nal-Tet-Sxt
Chl-Kan-Nal-Str-Sul-Tet-Sxt
Chl-Kan-Nal-Sul-Tet
Chl-Nal-Str-Sul-Tet-Sxt
Chl-Sul-Tet-Sxt
Nal-Str-Sul-Tet-Sxt
Nal-Str-Sul-Tet
Nal-Sul-Tet-Sxt
Str-Sul-Tet
Sul-Tet
Tet
Sxt

Integron

Total

+

-

(n=15)

(n=15)

(n=30)

2
0
1
1
1
1
1
1
0
1
1
0
0
0
0
2
0
1
0
1
0
0
1
0
0
0

0
1
0
0
0
0
0
0
2
0
0
1
1
1
1
0
1
0
1
0
1
1
0
1
2
1

2
1
1
1
1
1
1
1
2
1
1
1
1
1
1
2
1
1
1
1
1
1
1
1
2
1

1

Amp, Ampicillin; Chl, Chloramphenicol; Kan, Kanamycin; Gen, Gentamycin; Nal,
Nalidixic Acid; Str, Streptomycin; Sul, Sulfamethoxazole; Tet, Tetracycline; Sxt,
Trimethoprim/Sulfamethoxazole.
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trimethoprim/sulfamethoxazole was more common in integron-positive isolates
compared with integron-negative isolates (P<0.05) (Figure 10).
A comparison between Salmonella isolates of sows from Thailand and the US is
shown in Figure 11. Resistance to gentamicin, kanamycin, streptomycin, ampiciilin,
chloramphenicol, nalidixic acid, sulfamethoxazole, trimetroprim/sulfamethoxazole and
tetracycline was found in E. coli isolates in both countries. In addition, only resistance to
nalidixic acid was found to be significantly higher in Thailand isolates (P>0.05).
In agreement with E. coli isolates and Salmonella isolates from market pigs,
integron-positive isolates from sows tended to be resistant to a higher number of
antibiotics than integron-negative isolates, with integron-positive isolates from sows
demonstrating resistance to 7 to 9 antibiotics; whereas integron-negative isolates were
resistant to 1 to 6 antibiotics. A comparison of isolates from the US and Thailand showed
that US isolates were resistant to 1 to 8 antibiotics, whereas Thailand isolates were
resistant to 2 to 9 antibiotics (Figure 12).
A total of 16 patterns were observed among 20 Salmonella isolates from sows.
The most frequent pattern was resistance to 9 antimicrobials, Amp-Chl-Kan-Gen-Nal-StrSul-Tet-Sxt, which was found in 15% of isolates. No common pattern was found between
both integron-positive and integron-negative isolates in both countries (Table 8).
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Figure 10. Frequency of resistance to 16 antimicrobials in integron-positive and
integron-negative Salmonella spp. from sows.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline.
2
Bars within antibiotic with * differ (P<0.05).

173

100
90

the US
Thailand

80

*

% of resistant isolates

70
60
50
40
30
20
10

Te
t

t
Sx

l
Su

Na
l

Ci
p

Ch
l

Ax
o

T io

Fo
x

Cp
l

Au
g

Am
p

St r

n
Ka

n
Ge

Am
i

0

Antibiotics1,2
Figure 11. Frequency of resistance to 16 antimicrobials in Salmonella spp. of sow
isolates from the US and Thailand.
1
Ami, Amikacin; Gen, Gentamicin; Kan, Kanamycin; Str, Streptomycin; Amp,
Ampicillin; Aug, Amoxicillin/Clavulanic Acid; Cpl, Cephalothin; Fox, Cefoxitin; Tio,
Ceftiofur; Axo, Ceftriaxone; Chl, Chloramphenicol; Cip, Ciprofloxacin; Nal, Nalidixic
Acid; Sul, Sulfamethoxazole; Sxt, Trimethoprim/Sulfamethoxazole; Tet, Tetracycline
2
Bars within antibiotic with * differ (P<0.05).
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Figure 12. Multiple antimicrobial resistance of Salmonella spp. isolates from sows.
A. Integron-positive and integron-negative isolates.
B. Isolates from the US and Thailand.
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Table 8. Antibiograms of Salmonella spp. isolates of sows from the US and Thailand.
No. of isolate(s)
Pattern
No.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Antibiogram1

Amp-Chl-Kan-Gen-Nal-StrSul-Tet-Sxt
Amp-Chl-Kan-Gen-Str-SulTet-Sxt
Amp-Chl-Kan-Nal-Str-SulTet-Sxt
Amp-Chl-Str-Sul-Tet-Sxt
Amp-Chl-Str-Sul-Tet
Amp-Kan-Gen-Nal-Str-SulTet-Sxt
Amp-Kan-Gen-Nal-Sul-Tet
Amp-Kan-Gen-Str-Sul-Tet-Sxt
Amp-Kan-Gen-Sul-Tet
Amp-Kan-Nal-Str-Sul-Tet-Sxt
Amp-Kan-Sul-Tet-Sxt
Amp-Nal-Tet
Amp-Sul-Tet
Chl-Gen-Tet
Sul-Tet
Tet

Integron

Location

Total

+

-

US

Thailand

(n=10)

(n=10)

(n=10)

(n=10)

(n=20)

3

0

0

3

3

2

0

2

0

2

1

0

0

1

1

0
0
2

1
1
0

0
0
2

1
1
0

1
1
2

0
1
0
1
0
0
0
0
0
0

1
0
1
0
1
1
1
1
1
1

0
1
1
0
1
0
1
1
0
1

1
0
0
1
0
1
0
0
1
0

1
1
1
1
1
1
1
1
1
1

1

Amp, Ampicillin; Chl, Chloramphenicol; Kan, Kanamycin; Gen, Gentamycin; Nal,
Nalidixic Acid; Str, Streptomycin; Sul, Sulfamethoxazole; Tet, Tetracycline; Sxt,
Trimethoprim/Sulfamethoxazole.
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IV. DISCUSSION
Prevalence of Bacterial Isolates
The prevalences of E. coli and Salmonella spp. in market pigs and sows from the
US and Thailand were determined in this study. Our results show that the prevalence of
E. coli is high in both types of swine and both countries with over 80% of animals were
found to carry this bacterium, as was our expectation. The prevalence of Salmonella in
market pigs was much lower than that of E. coli but was not different between the 2
countries with only 3.4% and 5.7% of market pigs from Thailand and the US respectively
found to carry Salmonella. In sows, however, the prevalence of Salmonella was higher in
the US when compared with Thailand, with 60.9% of sows from the US found to carry
Salmonella isolates whereas only 8.5% of sows from Thailand were found to be positive
for that organism. The differences in Salmonella prevalence in sows may be due to the
differences of culture collection. While Salmonella isolates from sows in Thailand were
collected from live animals on farm, Salmonella isolates from the US were collected from
killed sows at the slaughterhouse. The stress caused by transportation of animals from
farm to slaughterhouse has been reported to result in increased Salmonella shedding (4,
37, 42). Hurd et al. (21, 22) noted that a serotype of Salmonella not found in fecal
samples from pigs on farms was isolated from intestinal contents at slaughter, suggesting
infection occurred during transport or at the slaughterhouse. Davies et al. (11, 12)
reported that although breeding herds may be a minor source of infection for finisher
pigs, they can play an important role in the maintenance of Salmonella on farms and in its
transmission to other farms.
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Prevalence of Class 1 Integrons
It is well known that class 1 integrons play an important role in dissemination of
antibiotic resistance in the enteric bacteria. Our results show that class 1 integrons, as
indicated by the presence of IntI1 gene, are widespread among E. coli and Salmonella
isolates of swine. More than 60 and 30% of E. coli isolates, and more than 50 and 25% of
Salmonella isolates from swine in Thailand and the US, respectively, carried class 1
integron.
The prevalence of class 1 integrons in both types of bacteria and both types of
swine were associated with the isolate origin. Class 1 integrons were more prevalent in
Thailand compared to the US.
With the exception of E. coli isolates from Thailand, we also noted a higher
prevalence of integrons in isolates collected from sows. It may be that as sows spend a
longer time on farm (3 to 5 years, compared with approximately 6 months for market
pigs), they have more opportunity for exposure to antibiotics and thus present a greater
opportunity for a resistant microflora to develop.
It is important to note that only 11.1% and 16.2% of intI1-positive E. coli and
Salmonella isolates from swine were found to carry qacEΔ1 and sul1; whereas almost all
of the E. coli (96.8%) carried qacEΔ1 and sul1. In agreement with this study, our earlier
study in chickens showed that 32.5%, 75.4%, and 82.9% of intI1-positive E. coli, P.
mirabilis, and Salmonella isolates from Thailand were carried qacEΔ1 and sul1. van
Essen-Zandbergen noted that only a subset of Salmonella and E. coli isolates carrying
intI1 also carry the 3’ conserved sequence (55). Sunde (50) reported that a high
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proportion of class 1 integrons found in E. coli lacked the sul1 gene. Additionally, Guerra
et al. (18) found defective integrons which lacked both qacEΔ1 and sul1, or only sul1, in
some E. coli isolates from Germany, suggesting that use of specific primers to detect
conserved segments alone can produce false negatives when those specific gene
components are not present in otherwise functional integrons.

Antibioticl susceptibility
Antibiotic resistance to at least 1 antibiotic was found in 97% of combined E. coli
and Salmonella isolates from swine in this study. Resistance to tetracycline,
sulfamethoxazole, streptomycin, and ampicillin was most common in swine, in
agreement with other studies (18, 25, 27, 32, 45, 48, 52, 54)
When comparing the frequency of antibiotic resistance between integron-positive
and integron-negative isolates, we found that integron-positive isolates were more likely
to be resistant to streptomycin than integron-negative isolates in both bacteria tested and
in both types of swine. A higher prevalence of resistance to sulfamethoxazole and
trimetroprim/sulfamethoxazone was also noted in integron-positive E. coli isolates. This
likely occurred because all integron-positive isolates contained sul1 as an integral part of
the integron. Similar to our study, Shahada et al. (47) reported all of the intI1-positive S.
enterica serovar Infantis isolates were resistant to sulfamethoxazole. Streptomycin and
trimethoprim are not only frequently found as a single gene cassette in integrons but also
these two genes were often found in combination within the same integron, as reported
by several research groups (20, 23, 26, 35, 49, 55). This co-selection may explain the
high prevalence of resistance to these antibiotics in integron-positive bacteria.
179

It should, however, be noted that the resistance phenotypes were only partially
explained by the presence of integrons. In agreement with our study, a study of
occurrence of integrons and antimicrobial resistance genes among Salmonella enterica in
Brazil revealed that integron-mediated resistance genes contributed to the multiresistance
phenotypes observed in the isolates; however, most resistance genes were located outside
the integron structure as independent genes. It was suggested that multiple resistance
genes might also be located on a single conjugative plasmid (39). In addition, a study of
antimicrobial resistance patterns and class 1 integrons among E. coli and S. enterica
serovar Choleraesuis strains isolated from humans and swine in Taiwan discovered that
class 1 integrons examined did not support the total resistance phenotypes observed
among both bacterial isolates. The investigators suggested that this may be due to
chromosomal mutation or the presence of other undetected integron classes (20).
There were no E. coli isolates from sows in Thailand or Salmonella isolates from
market pig in the US which carried all three class 1 integron conserved genes. This
prohibited a comparison of antibiotic resistance prevalence of those bacteria in Thailand
and the US. Nevertheless, our results from E. coli from market pigs showed that
resistance to gentamicin, ampicillin, cephalothin, chloramphenicol, ciprofloxacin,
nalidixic acid, trimethoprim/sulfamethoxazole of E. coli isolates from market pigs and
nalidixic acid of Salmonella isolates from sows were higher in Thailand isolates. Our
earlier study of chickens indicated that E. coli, P. mirabilis, and Salmonella isolates from
Thailand demonstrated a higher prevalence of chloramphenicol, nalidixic acid, and
trimethoprim/sulfamethoxazole than isolates from the US. Whereas, both E. coli and
Salmonella isolates from the US were statistically more likely to be resistant to
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amoxicillin/clavulanic acid, cefoxitin, and ceftiofur than those from Thailand. Salmonella
and P. mirabilis isolates from the US also demonstrated a higher prevalence of resistance
to cephalothin than isolates from Thailand. It is interesting to note that all E. coli and
Salmonella isolates from swine in the US and Thailand were susceptible to
amoxicillin/clavulanic acid, cefoxitin, ceftiofur, ceftriazole, and less than 2% of bacterial
isolates from swine were resistant to amikacin, which may be due to the limited use of
this antibiotic in swine production. Low levels of ceftriaxone and ceftiofur resistance
were also observed from previous studies conducted in Thailand (37, 40). The
distribution of antimicrobial resistance phenotypes are expected to reflect different use
patterns of antimicrobial agents in each type of animal and each countries (1, 16, 34)
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V. CONCLUSIONS
Antimicrobial resistance genes and class 1 integrons are common in bacteria
associated with swine in both Thailand and the US. While multi-antibiotic resistance is
associated with integrons, and specific multi-resistance patterns were often characteristic
of integron carriage, many multi-resistant isolates with a variety of antibiograms also
lacked class 1 integrons. Our work indicates that integrons and multi-antibiotic resistant
bacteria appear to be a significant aspect of microbial communities associated with
swine.
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CHAPTER 5 : POTENTIAL FOR CLASS 1 INTEGRONS TRANSFER
BETWEEN E. COLI AND SALMONELLA SPP.
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ABSTRACT
A study was conducted to determine if homologous integrons could be detected in
E. coli and Salmonella derived from the same animal or farm, from among swine or
poultry farms in the US and Thailand. Class 1 integron variable regions were detected
using a PCR targeting conserved integron sequences. When integron-positive E. coli and
Salmonella isolates had identical amplicon patterns, the PCR product was sequenced to
determine homology. Nine different amplicons with sizes ranging from 0.5 to 2.5 kb were
observed in bacterial isolates, and we found a single farm on which similar integrons
were found in both E. coli and Salmonella. Sequence analysis revealed that a 1.0 kb
amplicon found in both E. coli and Salmonella isolated from the farm contained an
aadA1 gene cassette encoding aminoglycosides 3’-adenyltransferase, which confers
resistance to streptomycin and spectinomycin. A 2.0 kb amplicon also found in both
types of bacteria containing the aadA5 gene encoding aminoglycosides 3’adenyltransferase, an additional reading frame with unknown function, orfD, as well as a
dfrA17 gene encoding dihydrofolate reductase, conferring resistance to trimethoprim. Our
results indicate that identical integrons were found in Salmonella and E. coli from a
single farm, likely indicating transfer between these two organisms occurs in vivo via
exchange of plasmids. Ours may be among the first studies to detect such transfer of
integrons and resistance genes between commensal bacteria and a foodborne pathogen
within a single farm.
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I. INTRODUCTION
When antibiotics are used in animals, selection for resistance to those drugs may
occur, not only in transient pathogenic bacteria, but also in commensal bacteria which
continually live in intestinal tract. The result may be increased reservoirs of resistant
organisms (32). In recent years, many resistance genes isolated from bacteria have been
mapped to specific genome sites known as integrons. Integrons have been found in
plasmids, transposons, and as independent units on bacterial chromosomes (4, 5, 17).
Integrons contain three elements that allow site-specific recombination of antibiotic
resistance genes. These elements include: 1) a recombination or attachment site; 2) an
integrase, that recognizes specific sequences on the extra-integron gene cassette and the
recombination site; and 3) a strong promoter that allows the integron to act as an
expression vector in the event of the incorporation of promoterless cassettes (9, 14). As
such, bacteria that harbor integrons may have an enhanced ability to rapidly acquire
resistance to multiple antibiotics and to promote the transfer of highly stable and selfpromoting resistance factors across their own and other bacterial species. Thus, bacteria
containing integrons pose a particularly insidious threat to the efficacies of current as
well as future antimicrobials. And while it is proposed that the primary vehicle for
transfer of bacterial resistance genes from animal hosts to human hosts is through food
borne bacteria, the large pool of naturally occurring nonpathogenic bacteria in the gut,
including E. coli, have been proposed to act as a reservoir of and/or vector for
transferable resistance genes. These commensal bacteria, by their residence in the GI
tract, are subject to exposure from antibiotics included in feeds and water, and they have
been shown to acquire resistance following such exposure (25, 26, 28) demonstrating a
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higher prevalence of resistance genes and genetic resistance elements, including
integrons (13).
It is widely accepted that resistance genes are transferable across species of
bacteria, and thus the potential exists for transfer from resident E. coli and other naturally
occurring bacteria to transient animal and human pathogens, including Salmonella.
However, to date, little evidence has been presented to clearly show that such transfer is
common in vivo. As a possible indication of gene transfer, we therefore determined the
degree of homology of resistance genes and integron sequences between those two
groups of bacteria within animals and farms.
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II. MATERIALS AND METHODS
Bacterial Isolates
In this study E. coli and Salmonella spp. derived from a previous study were
analyzed. We selected isolates for which both bacterial species within a farm were found
to contain all three conserved sequences of class 1 integrons, intI1, qacEΔ1, and sul1.
This criteria resulted in inclusion of 571 E. coli and 98 Salmonella spp. isolates from
chickens from Thailand and the US, sows from the US, and market pigs from Thailand
(Table 1).

Detection of Class 1 Integrons Variable Region by PCR
Class 1 integron variable regions were detected using a PCR targeting 5’ and 3
conserved sequences of class 1 integrons (21). Primer pairs were manufactured by
Integrated DNA Technologies, Inc. (San Diego, CA) (Table 2). Total DNA was prepared
by boiling overnight cultures in 2YT broth (Difco, Spark, MD) in an equal volume of
0.2% (wt/vol) Triton X-100 (Mallinckrodt, Paris, KY) for 5 min (20). Boiled cultures
were cooled on ice for 5 min and used immediately for PCR. The PCR solution was
composed of 12.5 μl 2X PCR Master Mix (Promega, Medison, WI), 1.5 μl each primer
(10 pmol/μl), 8.5 μl nuclease free water, and 1 μl DNA template. Reactions were
conducted in a Mastercyler Gradient thermocycler (Eppendorf, Westbury, NJ) with the
following conditions: 1) initial denaturation at 94°C for 3 min;

2) 35 cycles of

denaturation at 94°C for 3 min, annealing at 60°C for 30 s; extension at 72°C for 2
min 30 s; and 3) final extension at 72°C for 5 min. Amplicons were analyzed via
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Table 1. Source and number of bacteria possessing all three conserved sequence genes.

Animal

Countries

Chickens

Thailand
US

Sows
Market Pigs

US
Thailand

Farms
TH1
US3
US6
USE
THA
THD

Bacteria
E. coli

Salmonella

353
58
146
1
12
1

53
1
2
11
25
6
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Table 2. Primer pairs used for PCR.

Primer
Class 1 integrons
5’CS-F
3’CS-R
E. coli housekeeping genes
aspc-F
aspc-R
icdA-F
icdA-R
Salmonella housekeeping genes
fhuA-F
fhuA-R
glnA-F
glnA-R

Sequence (5’ to 3’)

GGCATCCAAGCACAAGC
AAGCAGACTTGACTGAT
GTTTCGTGCCGATGAACGTC
AAACCCTGGTAAGCGAAGTC
CTGCGCCAGGAACTGGATCT
ACCGTGGGTGGCTTCAAACA
AGAAGAAACCATTACCGTAACCG
TGCTAACCATCGAAATGATACCG
GTTATCGACCCGTTCTTCGC
GTTGGTGCCGTTCTTCGCC

Amplicon
size (bp)
Variable
594
669
402
579
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electrophoresis on a 1.0% agarose gel, and a 1 kb ladder (Promega, Medison, WI), was
used as a molecular size marker. Gels were stained with ethidium bromide for
visualization.

Location of Class 1 Integrons
When integron-positive E. coli and Salmonella isolates had identical amplicon
patterns, further analysis was conducted to detect the location of the integron. To
determine if class 1 integrons were carried on plasmids, plasmid DNA was extracted
from bacteria cells using QIAprep Spin Miniprep kit (Qiagen, Maryland). Resulting DNA
was subjected to a PCR analysis for detection of aspc and icdA chromosomal
housekeeping genes for E. coli (27), and fhuA and glnA chromosomal housekeeping
genes for Salmonella (35), using primers presented in Table 1, with PCR conditions used
to detect class 1 integron variable regions. A positive control consisting of total DNA
from each isolate was included to confirm efficiency of the PCR procedure. Absence of
amplified products in the plasmid DNA prep and presence of appropriate amplified
products (aspc and icdA for E. coli isolates, and fhuA and glnA for Salmonella isolates) in
the control sample provided assurance that the plasmid solution was free of chromosomal
contaminants. Plasmid DNA was then subjected to a PCR analysis for detection of class 1
integron variable regions, using the same primers and conditions as above. Successful
amplification of the variable region gene products was considered proof that the gene was
associated with the plasmid.
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Cloning and Sequencing
When integron-positive E. coli and Salmonella isolates were found to possess
identical amplicon patterns, randomly chosen CS-PCR products were sequenced. The
CS-PCR amplicon product was purified from 1% agarose gel using QIAquick Gel
Extraction Kit (Qiagen, Maryland) and cloned in the pGEM-T Vector (Promega, USA).
Colonies carrying the target fragment were picked by blue-white screening from LuriaBertani plates containing ampicillin 100 μg/ml, 40 μl 100 mM IPTG per plate and 40 μl
2% X-Gal per plate. Plasmid DNA from white colonies was checked for the presence of
the target fragment by purification with a QIAprep Spin Miniprep kit (Qiagen, Germany).
The CS-fragment was sequenced using SP6 and T7 primers (Promega, USA) at
the University of Tennessee Molecular Biology Resource Facility (Knoxville, TN).
Sequences obtained were compared to those in the GenBank database using the BLAST
algorithm available at the National Center for Biotechnology Information website
(www.ncbi.nlm.nih.gov)
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III. RESULTS
Six different variable region amplicon sizes ranging from 0.7 to 2.0 kb were
found among 353 E. coli isolates from chicken farm in Thailand. Thus, class 1 integrons
carrying gene cassettes were classified into 6 groups according to amplicon pattern. The
most frequent pattern was a 0.7 kb amplicon which was found in 123 isolates (35%).
Salmonella spp. isolates from chicken farms in Thailand possessed 2 sizes of amplicons,
1.0 and 1.25 kb, with the 1.0 kb amplicon being the most common (89% of isolates). E.
coli isolates from one farm in the US produced three different sizes of amplicons, 0.9,
1.6, and 2.5 kb, and 1.0, 1.6, and 2.5 kb whereas the other produced 4 different sizes, 1.0,
1.6, 2.0, and 2.5 kb. The combination of 1.6 and 2.5 kb was the most common pattern in
both farms. Only one amplicon, the 1.0 kb, was found in Salmonella from both chickens
farms in the US. Only one E. coli isolate from US sows was analyzed for variable regions
and those were found to carry integron patterns with combinations of 1.0 and 1.6 kb
amplicons. All 11 Salmonella isolates from sows carried the 1.0 kb amplicon. Among
two market pig farms in Thailand, all E. coli isolates from one farm carried the 1.6 kb
amplicon, whereas Salmonella isolated from the same farm carried the 1.0 kb amplicon.
Four different sizes of amplicons were found in E. coli isolates from another farm, with
those being 0.5, 1.0, 1.6, and 2.0 kb in size. The presence of class 1 integrons carrying
gene cassettes resulted in classification into 4 groups with the 2.0 kb, and co-existence of
1.0 and 2.0 kb, being the most common patterns found in this group. The same 2 patterns
of gene cassettes were found in Salmonella isolates from this farm (Table 3).
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Table 3. Gene cassette arrays of class 1 integrons among E. coli and Salmonella from
chickens, sows, and market pigs.

Animal

Chickens

Countries

Farms

Thailand

TH1

US

US3
US6

Sows

US

Market pigs Thailand

USE
THA

THD

1

Integron
group
TH1-1
TH1-2
TH1-3
TH1-4
TH1-5
TH1-6
TH1-7
TH1-8
US3-1
US3-2
US3-2
US6-1
US6-2
US6-3
US6-4
USE-1
USE-2
THA-1
THA-21
THA-31
THA-4
THD-1
THD-2

Approximate
size of
amplicon (kb)
0.7
0.7, 0.9
0.7, 1.0
0.9,1.6
1.0, 1.75
0.9, 1.25, 2.0
1.0
1.25
1.6, 2.5
0.9, 1.6, 2.5
1.0
1.6, 2.5
1.0, 1.6, 2.0
1.0, 1.6, 2.5
1.0
1.0,1.6
1.0
1.6
2.0
1.0, 2.0
0.5, 1.0, 2.0
1.6
1.0

No. (%) of strain
carrying gene cassettes
E. coli
123 (35)
47 (13)
112 (32)
13 (4)
47 (13)
11 (3)
0 (0)
0 (0)
45 (78)
13 (22)
0 (0)
86 (59)
37 (25)
23 (16)
0 (0)
1 (100)
0 (0)
1 (8)
4 (33)
4 (33)
3 (25)
1 (100)
0 (0)

Salmonella
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
47 (89)
6 (11)
0 (0)
0 (0)
1 (100)
0 (0)
0 (0)
0 (0)
2 (100)
0 (100)
11 (100)
0 (0)
8 (32)
17 (68)
0 (0)
0 (0)
6 (100)

Integron group found in both E. coli and Salmonella spp.
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Patterns of class 1 integrons carrying gene cassette in market pigs from Thailand
are shown in Figure 1. Overall, among E. coli and Salmonella from 6 farms in this study
only one market pig farm from Thailand possessed both integron-positive E. coli and
Salmonella isolates with identical amplicon patterns; we therefore used isolates from that
farm, and demonstrating that pattern, for further study.
E. coli and Salmonella housekeeping genes were detected in total DNA of each
isolate; and were not detected in plasmid solutions. This provides assurance that the
plasmid solution was free of chromosomal DNA, and suggests that integron sequences
were associated with plasmids.
Sequence analysis revealed that the 1.0 kb amplicon from both E. coli and
Salmonella contained the aadA1 gene cassette encoding aminoglycoside 3’adenyltransferase, which confers resistance to streptomycin and spectinomycin. In
contrast to the 1.0 kb amplicon, the 2.0 kb amplicon found in both types of bacteria had
an additional unknown reading frame, orfD, as well as a dfrA17 gene cassette which
encodes dihydrofolate reductase, conferring resistance to trimethoprim.
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Figure 1. PCR detecting class 1 integron variable regions in bacterial isolates from
market pigs.
Lane 1, 6, and 11; 1 kb DNA ladders; Lane 2-5; E. coli isolates; and Lane 7-10;
Salmonella isolates.
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IV. DISCUSSION
Antibiotic use in food animals targets pathogenic bacteria; however, when used,
such compounds not only affect pathogenic bacteria, but also the commensal organisms
that make up the major part of the gastrointestinal flora. These bacteria may function as a
reservoir of resistance genes that can be transferred to pathogenic bacteria (25). It is now
well established that many antibiotic resistance genes found in the Enterobacteriaceae
are located on integrons (6). Integrons provide an efficient mechanism for capturing and
exchanging a wide range of resistance genes. Four classes of integrons have been
identified, and among them, class 1 integrons are the most prevalent (32).
Characterization of gene transfer DNA elements has mainly been conducted in
vitro. However, the situation in vivo might be quite different, where a multitude of
heterogeneous bacterial communities might facilitate, or dilute, the spread of resistance
genes (1). We therefore investigated the potential for class 1 integrons transfer between
commensal E. coli and pathogenic Salmonella in the farm environment.
The location of integrons within bacterial genetic structures has an effect on the
stability and rate of dissemination of resistance genes. Integrons located on the
chromosome can persist in bacteria for long periods of time; however transfer of such
would typically be vertical. On the other hand, integrons located on plasmids are more
easily transferred horizontally, as well as vertically. Our results show that class 1
integrons in this study were associated with plasmids. In agreement with our study,
several researchers reported the presence of class 1 integrons on plasmids. For instance, a
recent study of variable gene cassette patterns of class 1 integron-associated drug
resistant E. coli in Taiwan revealed that class 1 integrons and dfrA17-aadA5 gene
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cassettes were located on the same transferable plasmids and were capable of
transmission (5, 30). Vo et al. (29) investigated antimicrobial resistance, class 1 integrons
and a novel variant of genomic island 1 in Salmonella isolates from Vietnam and found
most integrons were associated with conjugative plasmids. They further suggested that
those genes could transfer their antimicrobial resistance determinants to E. coli or S.
Enteritidis; or to Salmonella Genomic Island 1 or variants of that genetic element.
Our sequencing results revealed that the 1.0 kb amplicon from both E. coli and
Salmonella contained an aadA1 gene cassette encoding for aminoglycoside 3’adenyltransferase, conferring resistance to streptomycin and spectinomycin. A 2.0 kb
amplicon also found in both types of bacteria containing the aadA5 gene encoding
aminoglycosides 3’-adenyltransferase, an additional reading frame with unknown
function, orfD, as well as a dfrA17 gene encoding dihydrofolate reductase, conferring
resistance to trimethoprim. Those 2 types of amplicons were reported to be widespread in
different hosts at several locations around the world (5, 12, 13, 18-20, 24, 26-31).
Because E. coli and Salmonella isolates isolated from the same farms had similar
amplicon patterns and identical gene cassettes in the amplicon, and the integron was
found to be located on the plasmid in both species, this may indicate that transfer of class
1 integrons between these two bacteria occurred in the farm environment. It is important
to note; however, that the direction of transfer, whether from Salmonella to E. coli or E.
coli to Salmonella, is unknown, as our current molecular techniques do not distinguish
the direction of transmission (4).
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While this study did not focus on E. coli and Salmonella which did not share
similarity of class 1 integron patterns, a large proportion of bacterial isolates carried up to
3 amplicons in their integrons. This should be worrisome due to the fact that most
amplicons in class 1 integrons carry antibiotic resistant gene cassettes. Thus, it could be
suggested that a greater number of amplicons present in integrons would increase the
number of resistance genes that could be disseminated.
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V. CONCLUSIONS
Our study suggests that transfer of integrons between E. coli and Salmonella spp.
can occur in vivo within hosts or in farm environments. While such has been theorized by
experts, we may be among the first group to find evidence in that regard. Given the
numerous samples, animals, and farms sampled in the companion study that produced the
testable isolates for this study, as well as the number of integrons isolated, it appears that
transfer of integrons between these species may not occur at a high rate. Additionally, it
will be critical to determine the direction of transfer, as a primary concern is that
commensal bacteria, such as E. coli, that may be continuously exposed to feed based or
other antibiotic use in animal production, could acquire resistance and pass such to
transient pathogens, such as Salmonella.

That would appear to present a greater

immediate risk than the reverse transfer.
In all, our work provides additional knowledge regarding the complex nature of
antibiotic resistance gene acquisition, reservoirs and transfer, thus hopefully providing
additional information from which to determine courses of action and strategies for
control of this potential foodborne and/or zoonotic hazard.
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